Document:

<PAGE>

                                                                    EXHIBIT 10.2

                             COR Therapeutics, Inc.

                4.50% Convertible Senior Notes due June 15, 2006

                         Registration Rights Agreement
                         -----------------------------

                                                                   June 11, 2001

Goldman, Sachs & Co.
Robertson Stephens, Inc.
Credit Suisse First Boston Corporation
CIBC World Markets Corp.
Needham & Company, Inc.
 Goldman, Sachs & Co.
85 Broad Street
New York, New York  10004

Ladies and Gentlemen:

     COR Therapeutics, Inc., a Delaware corporation (the "Company"), proposes to
issue and sell to you  (the "Purchasers") upon the terms set forth in a purchase
agreement dated June 6, 2001 (the "Purchase Agreement"), between the Purchasers
and the Company, its 4.50% Convertible Senior Notes due June 15, 2006 (the
"Securities").  As an inducement to the Purchasers to enter into the Purchase
Agreement and in satisfaction of a condition to the obligations of the
Purchasers thereunder, the Company agrees with the Purchasers, (i) for the
benefit of the Purchasers and (ii) for the benefit of the Holders (as defined
below) from time to time of the Registrable Securities (as defined below),
including the Purchasers, as follows:

     1.  Definitions.  Capitalized terms used herein without definition shall
have the meanings ascribed to them in the Purchase Agreement or the Offering
Circular, each dated June 6, 2001, in respect of the Securities.  As used in
this Agreement, the following capitalized defined terms shall have the following
meanings:

     "Act" or "Securities Act" means the United States Securities Act of 1933,
as amended.

     "Affiliate" of any specified person means any other person which, directly
or indirectly, is in control of, is controlled by, or is under common control
with such specified person.  For purposes of this definition, "control" of a
person means the power, direct or indirect, to direct or cause the direction of
the management and policies of such person whether by contract or otherwise; and
the terms "controlling" and "controlled" have meanings correlative to the
foregoing.
<PAGE>

     "Closing Date" means the First Time of Delivery as defined in the Purchase
Agreement.

     "Commission" means the United States Securities and Exchange Commission.

     "Common Stock" means the common stock, par value $0.0001 per share, of the
Company, and any securities of the Company or any successor which may be
issuable upon conversion of the Securities pursuant to Article Eleven of the
Indenture.

     "DTC" means The Depository Trust Company.

     "Effectiveness Period" has the meaning set forth in Section 2(b) hereof.

     "Electing Holder" means any Holder of Registrable Securities that has
returned a properly completed and signed Notice and Questionnaire to the Company
in accordance with Section 3(b) hereof.

     "Exchange Act" means the United States Securities Exchange Act of 1934, as
amended.

     "Holder" means any person that is the record owner of Registrable
Securities (and includes any person that has a beneficial interest in any
Registrable Security in book-entry form).

     "Indenture" means the Indenture, dated as of June 11, 2001, between the
Company and Firstar Bank, N.A., as Trustee, as amended and supplemented from
time to time in accordance with its terms.

     "Managing Underwriters" means the investment banker or investment bankers
and manager or managers that shall administer an underwritten offering, if any,
as set forth in Section 6 hereof.

     "Person" means an individual, partnership, corporation, limited liability
company, trust or unincorporated organization, or a government or agency or
political subdivision thereof.

     "Prospectus" means the prospectus included in any Shelf Registration
Statement (including, without limitation, a prospectus that discloses
information previously omitted from a prospectus filed as part of an effective
registration statement in reliance upon Rule 430A under the Act), as amended or
supplemented by any prospectus supplement, with respect to the terms of the
offering of any portion of the Registrable Securities.

     "Registrable Security" means any Security and any share of Common Stock
issuable upon conversion or repurchase thereof except any such Security or share
of Common Stock which (i) has been effectively registered under the Securities
Act and sold in a manner contemplated by the Shelf Registration Statement, (ii)
has been transferred in compliance with Rule 144 under the Securities Act (or
any successor provision thereto) or is transferable pursuant to paragraph (k) of
such Rule 144 (or any successor provision thereto) ("Rule 144(k)"), or (iii) has
otherwise been transferred and a new Security or share of Common Stock not

                                      -2-
<PAGE>

subject to transfer restrictions under the Securities Act has been delivered by
or on behalf of the Company in accordance with Section 3.5(b) of the Indenture.

     "Shelf Registration" means a registration effected pursuant to Section 2
hereof.

     "Shelf Registration Statement" means a shelf registration statement of the
Company pursuant to the provisions of Section 2 hereof filed with the Commission
which covers some or all of the Registrable Securities, as applicable, on an
appropriate form under Rule 415 under the Act, or any similar rule that may be
adopted by the Commission, amendments and supplements to such registration
statement, including post-effective amendments, in each case including the
Prospectus contained therein, all exhibits thereto and all material incorporated
by reference therein.

     "Underwriter" means any underwriter of Registrable Securities in connection
with an offering thereof under a Shelf Registration Statement.

     2.   Shelf Registration.

     (a)  The Company shall, no later than 90 calendar days following the
Closing Date, file with the Commission a Shelf Registration Statement relating
to the offer and sale of the Registrable Securities by the Holders from time to
time in accordance with the methods of distribution elected by such Holders and
set forth in such Shelf Registration Statement and, thereafter, shall use its
reasonable efforts to cause such Shelf Registration Statement to be declared
effective under the Act within 180 calendar days following the Closing Date;
provided, however, that the Company may, upon written notice to all the Holders,
postpone having the Shelf Registration Statement declared effective for a
reasonable period not to exceed 90 days if the Company possesses material non-
public information, the disclosure of which would have a material adverse effect
on the Company and its subsidiaries taken as a whole; provided, further,
however, that no Holder shall be entitled to have the Registrable Securities
held by it covered by such Shelf Registration unless such Holder is an Electing
Holder.

     (b)  The Company shall use its reasonable efforts:

          (i) To keep the Shelf Registration Statement continuously effective in
     order to permit the Prospectus forming part thereof to be usable by Holders
     until the earliest of (1) the sale of all Registrable Securities registered
     under the Shelf Registration Statement; (2) the expiration of the period
     referred to in Rule 144(k) with respect to all Registrable Securities held
     by Persons that are not Affiliates of the Company; and (3) two years from
     the date (the "Effective Date") such Shelf Registration Statement is
     declared effective (such period being called the "Effectiveness Period");
     and

          (ii) After the Shelf Registration Statement is declared effective by
     the Commission, upon the request of an Electing Holder, to take action
     reasonably necessary to register the sale of any Registrable Securities of
     such Electing Holder and to identify such Electing Holder as a selling
     securityholder.

                                      -3-
<PAGE>

The Company shall be deemed not to have used its reasonable efforts to keep the
Shelf Registration Statement effective during the requisite period if the
Company voluntarily takes any action that would result in Holders of Registrable
Securities covered thereby not being able to offer and sell any such Registrable
Securities during that period, unless such action is required by applicable law
and the Company thereafter promptly complies with the requirements of paragraph
3(k) below.

     (c) The Company may suspend the use of the Prospectus for a period not to
exceed 45 days in any 90-day period or an aggregate of 90 days in any 365-day
period if the Board of Directors of the Company shall have determined in good
faith that because of valid business reasons (not including avoidance of the
Company's obligations hereunder), including the acquisition or divestiture of
assets, pending corporate developments and similar events, it is in the best
interests of the Company to suspend such use, and prior to suspending such use
the Company provides the Holders with written notice of such suspension, which
notice need not specify the nature of the event giving rise to such suspension.

     (d) Without limiting the remedies available to the Electing Holders under
Section 7 hereof, the Company acknowledges that any failure by the Company to
comply with its obligations under Section 2(a) hereof may result in material
irreparable injury to the Purchasers or the Electing Holders for which there is
no adequate remedy at law, that it will not be possible to measure damages for
such injuries precisely and that, in the event of any such failure, the
Purchasers or any Electing Holder may obtain such relief as may be required to
specifically enforce the Company's obligations under Section 2(a) hereof.

     3.  Registration Procedures.  In connection with any Shelf Registration
Statement, the following provisions shall apply:

     (a) The Company shall prepare and file with the Commission the Shelf
Registration Statement on the appropriate form under the Act (x) which form
shall be selected by the Company, (y) which form shall be available for the sale
of the Registrable Securities by the Electing Holders and (z) which Shelf
Registration Statement and any amendment thereto and the Prospectus forming part
thereof and any amendment or supplement thereto (and each other document
incorporated therein by reference in each case) shall comply as to form in all
material respects with the Act and the Exchange Act and the respective rules and
regulations thereunder and shall include (or incorporate by reference) all
financial statements required by the Commission to be filed therewith, and shall
use its reasonable efforts to cause such Shelf Registration Statement to become
effective and remain effective in accordance with Section 2 hereof.

         (b)  (1)  The Company shall mail the Notice and Questionnaire to the
     Holders of Registrable Securities not less than 25 calendar days prior to
     the time the Company intends in good faith to have the Shelf Registration
     Statement declared effective.   Any Person that acquires any Registrable
     Securities from an Electing Holder

                                      -4-
<PAGE>

     in compliance with the applicable provisions of the Securities (excluding
     any Registrable Securities that were not identified in the Notice and
     Questionnaire delivered by such Electing Holder) will be entitled to have
     such Registrable Securities included in the Shelf Registration Statement so
     long as such transferee provides the Company with an updated Notice and
     Questionnaire prior to the Questionnaire Deadline (as defined below).
     Subject to Section 3(b)(2) hereof, no Holder of Registrable Securities
     shall be entitled to be named as a selling securityholder in the Shelf
     Registration Statement as of the Effective Date, and no Holder of
     Registrable Securities shall be entitled to use the Prospectus forming a
     part thereof for offers and resales of Registrable Securities at any time,
     unless such Holder has returned a completed and signed Notice and
     Questionnaire to the Company by the deadline for response set forth therein
     (the "Questionnaire Deadline"), such response deadline to be on a date not
     less than 25 calendar days after the date of mailing of the Notice and
     Questionnaire by the Company.

          (2) After the Effective Date of the Shelf Registration Statement, the
     Company shall, upon the request of any Holder of Registrable Securities
     that is not then an Electing Holder, as promptly as reasonably practicable,
     send a Notice and Questionnaire to such Holder. The Company shall not be
     required to take any action to name such Holder as a selling securityholder
     in the Shelf Registration Statement until such Holder has returned a
     completed and signed Notice and Questionnaire to the Company. Following its
     receipt of such Notice and Questionnaire, the Company will reasonably
     promptly include the Registrable Securities covered thereby in the Shelf
     Registration Statement (if not previously included).

          (3) If such complete Notice and Questionnaire is received by the
     Company before 10 days prior to the Effective Date, such Holder shall be
     entitled to have its Registrable Securities included in the Shelf
     Registration Statement at the Effective Date. If the Company receives such
     complete Notice and Questionnaire after the 10th day prior to the Effective
     Date, the Registrable Securities covered by the Notice and Questionnaire
     will be included in the Shelf Registration Statement as promptly as
     reasonably practicable after receipt of such Notice and Questionnaire.

          (4) In the event that the Company receives such complete Notice and
     Questionnaire after the Shelf Registration Statement has been declared
     effective, the Company will, as promptly as reasonably practicable
     following receipt of the complete Notice and Questionnaire, file any
     amendments to the Shelf Registration Statement or supplements related to
     the Prospectus as are necessary to permit such Holder to deliver the
     Prospectus to purchasers of the Registrable Securities.  The Company shall
     use reasonable efforts to cause such post-effective amendment to the Shelf
     Registration Statement to be declared effective within 45 days of the
     filing of such post-effective amendment.  The Company may take reasonable
     steps to aggregate the addition of Registrable Securities of more than one
     Holder for purposes of filing amendments to the Shelf  Registration
     Statement or supplements to the Prospectus so as to reduce the

                                      -5-
<PAGE>

     need for multiple amendments or supplements, but the Company shall not
     utilize this provision to delay any filing requested by any of the
     Purchasers.

     (c) The Company shall furnish to the Holders, prior to the filing thereof
with the Commission, a copy of any Shelf Registration Statement, and each
amendment thereof and each amendment or supplement, if any, to the Prospectus
included therein and shall use reasonable efforts to reflect in each such
document, when so filed with the Commission, such comments as the Holders
reasonably may propose.

     (d) The Company shall take such action as may be necessary so that (i) any
Shelf Registration Statement and any amendment thereto and any Prospectus
forming part thereof and any amendment or supplement thereto (and each report or
other document incorporated therein by reference in each case) complies in all
material respects with the Securities Act and the Exchange Act and the
respective rules and regulations thereunder, (ii) any Shelf Registration
Statement and any amendment thereto does not, when it becomes effective, contain
an untrue statement of a material fact or omit to state a material fact required
to be stated therein or necessary to make the statements therein not misleading
and (iii) any Prospectus forming part of any Shelf Registration Statement, and
any amendment or supplement to such Prospectus, does not include an untrue
statement of a material fact or omit to state a material fact necessary in order
to make the statements, in the light of the circumstances under which they were
made, not misleading.

     (e)  (i)  The Company shall advise the Purchasers, the Electing Holders and
     the Managing Underwriter or Underwriters promptly and, if requested by the
     Purchasers or any Electing Holder, confirm such advice in writing:

               (1)  when a Shelf Registration Statement and any amendment
          thereto has been filed with the Commission and when the Shelf
          Registration Statement or any post-effective amendment thereto has
          become effective in each case making a public announcement thereof by
          release made to Reuters Economic Services and Bloomberg Business News;

               (2)  when the Company receives any request by the Commission for
          amendments or supplements to the Shelf Registration Statement or the
          Prospectus included therein or for additional information;

               (3)  when the Commission issues any stop order suspending
          effectiveness of the Shelf Registration Statement or initiates any
          proceedings for that purpose;

               (4)  when the Company receives any notification with respect to
          the suspension of the qualification of the securities included therein
          for sale in any jurisdiction or the initiation of any proceeding for
          such purpose; and

                                      -6-
<PAGE>

         (ii) The Company shall, as promptly as reasonably practicable, advise
     the Purchasers, the Electing Holders and each Managing Underwriter, if any,
     of the happening of any event that requires the making of any changes to
     the Shelf Registration Statement or the Prospectus so that, as of such
     date, the Shelf Registration Statement and the Prospectus do not contain an
     untrue statement of a material fact and do not omit to state a material
     fact required to be stated therein or necessary to make the statements
     therein (in the case of the Prospectus, in light of the circumstances under
     which they were made) not misleading (which advice shall be accompanied by
     an instruction to suspend the use of the Prospectus until the requisite
     changes have been made).

     (f) The Company shall use reasonable efforts to prevent the issuance, and
if issued to obtain the withdrawal, of any order suspending the effectiveness of
any Shelf Registration Statement at the earliest possible time.

     (g) The Company shall furnish to each Electing Holder, counsel for the
Purchasers, each Purchaser and each Managing Underwriter, if any, with respect
to a Shelf Registration Statement, without charge, at least one copy of such
Shelf Registration Statement and any post-effective amendment thereto, including
financial statements and schedules, and, if the Electing Holder so requests in
writing, all exhibits (including those incorporated by reference).

     (h) The Company shall, during the Effectiveness Period, deliver to each
Electing Holder and each Managing Underwriter, if any, with respect to a Shelf
Registration Statement, without charge, as many copies of the Prospectus
(including each preliminary Prospectus) included in such Shelf Registration
Statement and any amendment or supplement thereto as such Electing Holder may
reasonably request; and the Company consents (except during the continuance of
any event described in Section 3(e)(ii)) to the use of the Prospectus or any
amendment or supplement thereto by each of the Electing Holders in connection
with the offering and sale of the Registrable Securities covered by the
Prospectus and any amendment or supplement thereto during the Effectiveness
Period.

     (i) Prior to any offering of Registrable Securities pursuant to any Shelf
Registration Statement, the Company shall register or qualify or cooperate with
the Purchasers and their counsel in connection with the registration or
qualification of such Registrable Securities for offer and sale under the
securities or blue sky laws of such jurisdictions as any such Electing Holders
reasonably request in writing and do any and all other acts or things necessary
or advisable to enable the offer and sale in such jurisdictions of the
Registrable Securities covered by such Shelf Registration Statement; provided,
however, that in no event shall the Company be obligated to (i) qualify as a
foreign corporation or as a dealer in securities in any jurisdiction where it
would not otherwise be required to so qualify but for this Section 3(i), (ii)
file any general consent to service of process or taxation in any jurisdiction
where it is not as of the date hereof then so subject or (iii) subject itself to
taxation in any jurisdiction if it is not so subject.

     (j) Unless any Registrable Securities shall be in book-entry only form, the
Company shall cooperate with the Electing Holders to facilitate the timely
preparation and delivery of

                                      -7-
<PAGE>

certificates representing Registrable Securities to be sold pursuant to any
Shelf Registration Statement free of any restrictive legends and in such
permitted denominations and registered in such names as Electing Holders may
request in connection with the sale of Registrable Securities pursuant to such
Shelf Registration Statement.

     (k) Upon the occurrence of any event contemplated by paragraph 3(e)(ii)
above, the Company shall promptly prepare a post-effective amendment to any
Shelf Registration Statement or an amendment or supplement to the related
Prospectus or file any other required document so that, as thereafter delivered
to purchasers of the Registrable Securities included therein, the Prospectus
will not include an untrue statement of a material fact or omit to state any
material fact necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading.  If the Company
notifies the Electing Holders of the occurrence of any event contemplated by
paragraph 3(e)(ii) above, the Electing Holders shall suspend the use of the
Prospectus until the requisite changes to the Prospectus have been made.

     (l) Not later than the effective date of any Shelf Registration Statement
hereunder, the Company shall provide a CUSIP number for the Securities
registered under such Shelf Registration Statement.

     (m) The Company shall use reasonable efforts to comply with all applicable
rules and regulations of the Commission and shall make generally available to
their security holders or otherwise provide in accordance with Section 11(a) of
the Securities Act as soon as practicable after the effective date of the
applicable Shelf Registration Statement an earnings statement satisfying the
provisions of Section 11(a) of the Securities Act.

     (n) The Company shall cause the Indenture and the Securities to be
qualified under the Trust Indenture Act in a timely manner; and in connection
with such qualification, the Company shall cooperate with the Trustee under the
Indenture and the Holders (as defined in the Indenture) to effect such changes
to the Indenture as may be required for such Indenture to be so qualified in
accordance with the terms of the Trust Indenture Act; and the Company shall
execute and use all reasonable efforts to cause the Trustee to execute, all
documents that may be required to effect such changes and all other forms and
documents required to be filed with the Commission to enable such Indenture to
be so qualified in a timely manner.

     (o) In the event of an underwritten offering as set forth in Section 6
herein, the Company shall, if requested, promptly include or incorporate in a
Prospectus supplement or post-effective amendment to a Shelf Registration
Statement, such information as the Managing Underwriter or Underwriters
reasonably request to be included therein and to which the Company does not
reasonably object and shall make all required filings of such Prospectus
supplement or post-effective amendment as soon as practicable after it is
notified of the matters to be included or incorporated in such Prospectus
supplement or post-effective amendment.

                                      -8-
<PAGE>

     (p) The Company shall enter into such customary agreements (including
underwriting agreements in customary form) to take all other appropriate actions
in order to expedite or facilitate the registration or the disposition of the
Registrable Securities, and in connection therewith, if an underwriting
agreement is entered into, cause the same to contain indemnification provisions
and procedures substantially identical to those set forth in Section 5 (or such
other provisions and procedures acceptable to the Managing Underwriters, if any)
with respect to all parties to be indemnified pursuant to Section 5.

     (q)  The Company shall:

          (i)   make reasonably available for inspection by one or more
     representative of the Electing Holders designated in writing by the Holders
     of a majority of the Registrable Securities to be registered thereunder,
     any Underwriter participating in any disposition pursuant to such Shelf
     Registration Statement, and any attorney, accountant or other agent
     retained by such representative or any such Underwriter all relevant
     financial and other records, pertinent corporate documents and properties
     of the Company and its subsidiaries;

          (ii)  cause the Company's officers, directors and employees to make
     reasonably available for inspection all relevant information reasonably
     requested by such representative or any such Underwriter, attorney,
     accountant or agent in connection with any such Shelf Registration
     Statement, in each case, as is customary for similar due diligence
     examinations; provided, however, that any information that is designated in
     writing by the Company, in good faith, as confidential at the time of
     delivery of such information shall be kept confidential by such
     representative, any Holders or any such Underwriter, attorney, accountant
     or agent, unless such disclosure is made in connection with a court
     proceeding or required by law, or such information becomes available to the
     public generally or through a third party without an accompanying
     obligation of confidentiality;

          (iii) make such representations and warranties to the Electing
     Holders and the Underwriters, if any, in form, substance and scope as are
     customarily made by the Company to underwriters in primary underwritten
     offerings and covering matters including, but not limited to, those set
     forth in the Purchase Agreement;

          (iv)  use its reasonable efforts to obtain opinions of counsel to the
     Company and updates thereof (which counsel and opinions (in form, scope and
     substance) shall be reasonably satisfactory to the Managing Underwriters,
     if any) addressed to each Electing Holder and the Underwriters, if any,
     covering such matters as are customarily covered in opinions requested in
     underwritten offerings and such other matters as may be reasonably
     requested by such Electing Holders and Underwriters (it being agreed that
     the matters to be covered by such opinion or written statement by such
     counsel delivered in connection with such opinions shall include in
     customary form, without limitation, as of the date of the opinion and as of
     the effective date of the Shelf

                                      -9-
<PAGE>

     Registration Statement or most recent post-effective amendment thereto, as
     the case may be, the absence from such Shelf Registration Statement and the
     prospectus included therein, as then amended or supplemented, including the
     documents incorporated by reference therein, of an untrue statement of a
     material fact or the omission to state therein a material fact required to
     be stated therein or necessary to make the statements therein not
     misleading);

          (v) use its reasonable efforts to obtain "cold comfort" letters and
     updates thereof from the independent public accountants of the Company
     (and, if necessary, any other independent public accountants of any
     subsidiary of the Company or of any business acquired by the Company for
     which financial statements and financial data are, or are required to be,
     included in the Shelf Registration Statement), addressed to each Electing
     Holder and the Underwriters, if any, in customary form and covering matters
     of the type customarily covered in "cold comfort" letters in connection
     with primary underwritten offerings;

          (vi) deliver such documents and certificates as may be reasonably
     requested by any such Electing Holders and the Managing Underwriters, if
     any, including those to evidence compliance with Section 3(d) and with any
     customary conditions contained in the underwriting agreement or other
     agreement entered into by the Company.

     The foregoing actions set forth in clauses (iii), (iv), (v) and (vi) of
     this Section 3(p) shall be performed at each closing under any underwritten
     offering to the extent required thereunder (including at any closing
     relating to the exercise by underwriters of their over-allotment options,
     if any).

     (r)  The Company will use its reasonable efforts to cause the Stock
issuable upon conversion of the Securities to be admitted for quotation on the
Nasdaq National Market or other stock exchange or trading system on which the
Stock primarily trades on or prior to the effective date of any Shelf
Registration Statement hereunder.

     (s)  In the event that any broker-dealer registered under the Exchange Act
shall be an "Affiliate" (as defined in Rule 2720(b)(i) of the Rules of Conduct
of the National Association of Securities Dealers, Inc. (the "NASD") (or any
successor or analogous provision thereto)) of the Company or has a "Conflict of
Interest" (as defined in Rule 2720(b)(7) of the Rules of Conduct of the NASD (or
any successor an analogous provision thereto)) and such broker-dealer shall
underwrite, participate as a member of an underwriting syndicate or selling
group or "assist in the distribution" (within the meaning of such rule) of any
Registrable Securities, whether as a holder of such Registrable Securities or as
an underwriter, a placement or sales agent or a broker or dealer in respect
thereof, or otherwise, assist such broker-dealer (at the expense of such broker-
dealer) in complying with the requirements of such rule, including, without
limitation, by (A) engaging a "qualified independent underwriter" (as defined in
such rule) to participate in the preparation of the registration statement
relating to such Registrable Securities, to exercise usual standards of due
diligence in respect thereto and to recommend the public offering price of such
Registrable Securities, (B) indemnifying such

                                      -10-
<PAGE>

qualified independent underwriter to the extent of the indemnification of
Underwriters provided in Section 5 hereof, and (C) providing such information to
such broker-dealer as may be required in order for such broker-dealer to comply
with the requirements of the Rules of Conduct of the NASD.

     (t)  The Company shall use reasonable efforts to take all other steps
necessary to effect the registration, offering and sale of the Registrable
Securities covered by the Shelf Registration Statement contemplated hereby.

     (u)  The Company may require each Electing Holder with respect to a Shelf
Registration Statement to furnish to the Company such information regarding the
Electing Holder and the distribution of Registrable Securities held by such
Electing Holder as may be required by applicable law or regulation for inclusion
in such Shelf Registration Statement and the Company may exclude from such
registration the Registrable Securities of any Electing Holder that fails to
furnish such information within a reasonable time after receiving such request.

     4.   Registration Expenses.  Except as otherwise provided in Section 6, the
Company shall bear all fees and expenses incurred in connection with the
performance of its obligations under Sections 2 and 3 hereof and shall bear or
reimburse the Electing Holders for the reasonable fees and disbursements of a
single counsel selected by a plurality of all Electing Holders who own an
aggregate of not less than 25% of the Registrable Securities covered by the
Shelf Registration Statement to act as counsel therefor in connection therewith.
Each Electing Holder shall pay all underwriting discounts and commissions and
transfer taxes, if any, relating to the sale or disposition of such Electing
Holder's Registrable Securities pursuant to the Shelf Registration Statement.

     5.   Indemnification and Contribution.

     (a)  In connection with any Shelf Registration Statement, the Company shall
indemnify and hold harmless each Electing Holder, each Underwriter who
participates in an offering of Registrable Securities, each person, if any, who
controls any of such parties within the meaning of Section 15 of the Securities
Act or Section 20 of the Exchange Act and each of their respective directors,
officers, employees, trustees and agents, as follows:

          (i)  against any and all loss, liability, claim, damage and expense
     whatsoever, including any amounts paid in settlement of any investigation,
     litigation, proceeding or claim, joint or several, as incurred, arising out
     of any untrue statement or alleged untrue statement of a material fact
     contained in any Shelf Registration Statement (or any amendment thereto)
     covering Registrable Securities, including all documents incorporated
     therein by reference, or the omission or alleged omission therefrom of a
     material fact required to be stated therein or necessary to make the
     statements therein not misleading or arising out of any untrue statement or
     alleged untrue statement of a material fact contained in any Prospectus (or
     any amendment or supplement thereto) or

                                      -11-
<PAGE>

     the omission or alleged omission therefrom of a material fact necessary in
     order to make the statements therein, in the light of the circumstances
     under which they were made, not misleading; provided, that the Company
     shall not be liable under this clause (i) for any settlement of any action
     effected without its written consent, which consent shall not be
     unreasonably withheld; and

          (ii)  against any and all expenses whatsoever, as incurred (including
     reasonable fees and disbursements of counsel chosen by the Electing
     Holders, such Electing Holder or any Underwriter (except to the extent
     otherwise expressly provided in Section 5(c) hereof)), reasonably incurred
     in investigating, preparing or defending against any litigation, or any
     investigation or proceeding by any court or governmental agency or body,
     commenced or threatened, or any claim whatsoever based upon any such untrue
     statement or omission, or any such alleged untrue statement or omission, to
     the extent that any such expense is not paid under subparagraph (i) of this
     Section 5(a);

provided that this indemnity shall not apply to any loss, liability, claim,
damage or expense to the extent arising out of an untrue statement or omission
or alleged untrue statement or omission made in reliance upon and in conformity
with written information furnished to the Company by such Electing Holder or any
Underwriter in writing expressly for use in the Shelf Registration Statement (or
any amendment thereto) or any Prospectus (or any amendment or supplement
thereto).  Any amounts advanced by the Company to an indemnified party pursuant
to this Section 5 as a result of such losses shall be returned to the Company if
it shall be finally determined by such a court in a judgment not subject to
appeal or final review that such indemnified party was not entitled to
indemnification by the Company.

     (b)  Each Electing Holder shall agree, severally and not jointly, to
indemnify and hold harmless the Company, each Underwriter who participates in an
offering of Registrable Securities and the other Electing Holders and each of
their respective directors, officers (including each officer of the Company who
signed the Shelf Registration Statement), employees, trustees and agents and
each Person, if any, who controls the Company, any Underwriter or any other
Electing Holder within the meaning of Section 15 of the Securities Act or
Section 20 of the Exchange Act, from and against any and all loss, liability,
claim, damage and expense whatsoever described in the indemnity contained in
Section 5(a)(i) and (ii) hereof, as incurred, but only with respect to untrue
statements or omissions, or alleged untrue statements or omissions, made in the
Shelf Registration Statement (or any amendment thereto) or any Prospectus (or
any amendment or supplement thereto) in reliance upon and in conformity with
written information furnished to the Company by such Electing Holder expressly
for use in the Shelf Registration Statement (or any amendment thereto) or any
Prospectus (or any amendment or supplement thereto); provided, however, that, no
such Electing Holder shall be liable for any claims hereunder in excess of the
amount of net proceeds received by such Electing Holder from the sale of
Registrable Securities pursuant to the Shelf Registration Statement.

                                      -12-
<PAGE>

     (c)  Each indemnified party shall give prompt notice to each indemnifying
party of any action commenced against it in respect of which indemnity may be
sought hereunder, enclosing a copy of all papers served on such indemnified
party, but failure to so notify an indemnifying party shall not relieve it of
any liability which it may have to the indemnified party otherwise than on
account of this indemnity agreement.  An indemnifying party may participate at
its own expense in the defense of any such action.  If an indemnifying party so
elects within a reasonable time after receipt of such notice, such indemnifying
party, jointly with any other indemnifying party, may assume the defense of such
action with counsel chosen by it and approved by the indemnified party or
parties defendant in such action, provided that if any such indemnified party
reasonably determines that there may be legal defenses available to such
indemnified party which are different from or in addition to those available to
such indemnifying party or that representation of such indemnifying party and
any indemnified party by the same counsel would present a conflict of interest,
then such indemnifying party or parties shall not be entitled to assume such
defense.  If an indemnifying party is not entitled to assume the defense of such
action as a result of the proviso to the preceding sentence, counsel for such
indemnifying party shall be entitled to conduct the defense of such indemnifying
party and counsel for each indemnified party or parties shall be entitled to
conduct the defense of such indemnified party or parties.  If an indemnifying
party assumes the defense of an action in accordance with and as permitted by
the provisions of this paragraph, such indemnifying party shall not be liable
for any fees and expenses of counsel for the indemnified parties incurred
thereafter in connection with such action.  In no event shall the indemnifying
party or parties be liable for the fees and expenses of more than one counsel
(in addition to any local counsel) separate from its own counsel for all
indemnified parties in connection with any one action or separate but similar or
related actions in the same jurisdiction arising out of the same general
allegations or circumstances.

     (d)  In order to provide for just and equitable contribution in
circumstances in which the indemnity provision provided for in this Section 5 is
for any reason held to be unavailable to an indemnified party although
applicable in accordance with its terms, then each indemnifying party shall
contribute to the aggregate losses, liabilities, claims, damages and expenses of
the nature contemplated by such indemnity agreement incurred by such indemnified
party, as incurred; provided that no Person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act)
shall be entitled to contribution from any Person that was not guilty of such
fraudulent misrepresentation.  Each such indemnifying party shall contribute to
such aggregate losses, liabilities, claims, damages and expenses of such
indemnified party of the nature contemplated by such indemnity agreement in such
proportion as shall be appropriate to reflect the relative fault of such
indemnifying party, on the one hand, and such indemnified party, on the other
hand, with respect to the statements or omissions which resulted in such loss,
liability, claim, damage or expense, or action in respect thereof, as well as
any other relevant equitable considerations.  The relative fault of an
indemnifying party, on the one hand, and of an indemnified party, on the other
hand, shall be determined by reference to, among other things, whether the
untrue or alleged untrue statement of a material fact or the omission or alleged
omission to state a material fact relates to information supplied by such
indemnifying party, on the one hand, or by or on behalf of such indemnified
party, on the other,

                                      -13-
<PAGE>

and the parties' relative intent, knowledge, access to information and
opportunity to correct or prevent such statement or omission. The Company, the
Purchasers and the Holders of the Registrable Securities agree that it would not
be just and equitable if contribution pursuant to this Section 5(d) were to be
determined by pro rata allocation or by any other method of allocation that does
not take into account the relevant equitable considerations. For purposes of
this Section 5(d), each director, officer, employee, trustee, agent and Person,
if any, who controls a Purchaser or Holder within the meaning of Section 15 of
the Securities Act or Section 20 of the Exchange Act shall have the same rights
to contribution as such Purchaser or Holder, as the case may be, and each
director, officer, employee, trustee and agent of the Company, and each Person,
if any, who controls the Company within the meaning of Section 15 of the
Securities Act or Section 20 of the Exchange Act shall have the same rights to
contribution as the Company. No party shall be liable for contribution with
respect to any action, suit, proceeding or claim settled without its written
consent, which consent shall not be unreasonably withheld.

     (e)  The Company may require, as a condition to including any Registrable
Securities in any Registration Statement filed and to entering into any
underwriting agreement with respect thereto, that the Company shall have
received an undertaking reasonably satisfactory to it from the holder of such
Registrable Securities and from each Underwriter named in any such underwriting
agreement, severally and not jointly, to comply with the provisions of
paragraphs (a) through (d) of this Section 5.

     The indemnity and contribution provisions contained in this Section 5 shall
remain operative and in full force and effect regardless of (i) any termination
of this Agreement, (ii) any investigation made by or on behalf of the Managing
Underwriters, if any, any Electing Holder or any Person controlling any Electing
Holder, or by or on behalf of the Company, its officers or directors or any
Person controlling the Company and (iii) any sale of Registrable Securities
pursuant to the Shelf Registration Statement.

     6.   Underwritten Offering.  The Electing Holders who desire to do so may
sell Registrable Securities in an underwritten offering upon request to the
Company.  In any such underwritten offering, the investment banker or bankers
and manager or managers that will administer the offering will be selected by,
and the underwriting arrangements with respect thereto will be approved by the
Holders of a majority of the Registrable Securities to be included in such
offering; provided, however, that (i) such investment bankers and managers and
underwriting arrangements must be reasonably satisfactory to the Company and
(ii) the Company shall not be obligated to arrange for more than one
underwritten offering during the Effectiveness Period.  No Holder may
participate in any underwritten offering contemplated hereby unless such Holder
(a) agrees to sell such Holder's Registrable Securities in accordance with any
approved underwriting arrangements, (b) completes and executes all reasonable
questionnaires, powers of attorney, indemnities, underwriting agreements, lock-
up letters and other documents required under the terms of such approved
underwriting arrangements and (c) at least 20% of the outstanding Registrable
Securities are included in such underwritten offering.  The Holders
participating in any underwritten offering shall be responsible for any

                                      -14-
<PAGE>

expenses customarily borne by selling securityholders, including underwriting
discounts and commissions and fees and expenses of counsel to the selling
securityholders and shall reimburse the Company for the fees and disbursements
of their counsel, their independent public accountants and any printing expenses
incurred in connection with such underwritten offerings. Notwithstanding the
foregoing or the provisions of Section 3(o) hereof, upon receipt of a request
from the Managing Underwriter or a representative of Holders of a majority of
the Registrable Securities outstanding to prepare and file an amendment or
supplement to the Shelf Registration Statement and Prospectus in connection with
an underwritten offering, the Company may delay the filing of any such amendment
or supplement for up to 90 days if the Company in good faith has a valid
business reason for such delay.

     7.   Liquidated Damages

     (a)  Pursuant to Section 2(a) hereof, the Company may, upon written notice
to all the Holders, postpone having the Shelf Registration Statement declared
effective for a reasonable period not to exceed 90 days if the Company possesses
material non-public information, the disclosure of which would have a material
adverse effect on the Company and its subsidiaries taken as a whole.
Notwithstanding any such postponement, if (i) on or prior to the 90th day
following the Closing Date, a Shelf Registration Statement has not been filed
with the Commission or (ii) on or prior to the 180th day following the Closing
Date, such Shelf Registration Statement is not declared effective by the
Commission (each, a "Registration Default"), the Company shall be required to
pay liquidated damages ("Liquidated Damages"), from and including the day
following such Registration Default until such Shelf Registration Statement is
either so filed or so filed and subsequently declared effective, as applicable,
or, if earlier, the end of the Effectiveness Period, at a rate per annum equal
to an additional one-quarter of one percent (0.25%) of the principal amount of
Registrable Securities, to and including the 90th day following such
Registration Default and one-half of one percent (0.5%) thereof from and after
the 91st day following such Registration Default.

     (b)  In the event that the Shelf Registration Statement ceases to be
effective (or the Holders of Registrable Securities are otherwise prevented or
restricted by the Company from effecting sales pursuant thereto) (an "Effective
Failure") for more than 45 days, whether or not consecutive, in any 90-day
period, or 90 days, whether or not consecutive, during any 12-month period, then
the Company shall pay Liquidated Damages at a rate per annum equal to an
additional one-half of one percent (0.5%) from the 46th day of the applicable
90-day period or the 91st day of the applicable 12-month period, as the case may
be, that such Shelf Registration Statement ceases to be effective (or the
Holders of Registrable Securities are otherwise prevented or restricted by the
Company from effecting sales pursuant thereto) until the earlier of (i) the time
the Shelf Registration Statement again becomes effective or the Holders of
Registrable Securities are again able to make sales under the Shelf Registration
Statement or (2) the time the Effectiveness Period expires. For the purpose of
determining an Effective Failure, days on which the Company has been obligated
to pay Liquidated Damages in accordance with the foregoing in respect of a prior
Effective Failure within the applicable 90-day or 12-month period, as the case
may be, shall not be included.

                                      -15-
<PAGE>

     (c)  In the event the Company fails to file a post-effective amendment to
the Shelf Registration Statement, or the post-effective amendment is not
declared effective, within the periods required by Section 3(b)(4), the Company
shall pay Liquidated Damages at a rate per annum equal to an additional one-half
of one percent (0.5%) from and including the date of such Registration Default
until such time as such Registration Default is cured.

     (d)  Any amounts to be paid as Liquidated Damages pursuant to paragraphs
(a), (b) or (c) of this Section shall be paid semi-annually in arrears, with the
first semi-annual payment due on the first Interest Payment Date (as defined in
the Indenture), as applicable, following the date of such Registration Default.
Such Liquidated Damages will accrue (1) in respect of the Securities at the
rates set forth in paragraphs (a), (b) or (c) of this Section, as applicable, on
the principal amount of the Securities and (2) in respect of the Common Stock
issued upon conversion of the Securities, at the rates set forth in paragraphs
(a), (b) or (c) of this Section, as applicable, applied to the Conversion Price
(as defined in the Indenture) at that time.

     (e)  Except as provided in Section 2(d), the Liquidated Damages as set
forth in this Section 7 shall be the exclusive monetary remedy available to the
Holders of Registrable Securities for such Registration Default or Effective
Failure. In no event shall the Company be required to pay Liquidated Damages in
excess of the applicable maximum amount of one-half of one percent (0.5%) set
forth above, regardless of whether one or multiple Registration Defaults exist.

     8.   Miscellaneous.

     (a)  Other Registration Rights.  The Company may in the future grant
registration rights that would permit any Person that is a third party the right
to piggy-back on any Shelf Registration Statement, provided that if the Managing
Underwriter, if any, of such offering notifies the Electing Holders that the
total amount of securities which they and the holders of such piggy-back rights
intend to include in any Shelf Registration Statement is so large as to
materially adversely affect the success of such offering (including the price at
which such securities can be sold), then only the amount, the number or kind of
securities to be offered for the account of holders of such piggy-back rights
will be reduced to the extent necessary to reduce the total amount of securities
to be included in such offering to the amount, number or kind recommended by the
Managing Underwriter prior to any reduction in the amount of Registrable
Securities to be included.

     (b)  Amendments and Waivers.  The provisions of this Agreement, including
the provisions of this sentence, may not be amended, qualified, modified or
supplemented, and waivers or consents to departures from the provisions hereof
may not be given, unless the Company has obtained the written consent of
Goldman, Sachs & Co.

     (c)  No Inconsistent Agreements.  The Company has not entered into, and on
or after the date of this Agreement will not enter into, any agreement which is
inconsistent with the

                                      -16-
<PAGE>

rights granted to the Holders of Registrable Securities in this Agreement or
otherwise conflicts with the provisions hereof. The rights granted to the
Holders hereunder do not in any way conflict with and are not inconsistent with
the rights granted to the holders of the Company's other issued and outstanding
securities under any such agreements.

     (d)  Notices.  All notices and other communications provided for or
permitted hereunder shall be made in writing by hand-delivery, first-class mail,
telex, telecopier, or air courier guaranteeing overnight delivery:

          (1)  if to a Holder, at the most current address given by such Holder
     to the Company in accordance with the provisions of this Section 8(d);

          (2)  if to the Purchasers, initially at the address set forth in the
     Purchase Agreement; and

          (3)  if to the Company, initially at its address set forth in the
     Purchase Agreement.

All such notices and communications shall be deemed to have been duly given when
received.
     The Purchasers or the Company by notice to the other may designate
additional or different addresses for subsequent notices or communications.

     (e)  Successors and Assigns.  This Agreement shall inure to the benefit of
and be binding upon the successors and assigns of each of the parties and the
Holders, including, without the need for an express assignment or any consent by
the Company thereto, subsequent Holders of Registrable Securities.  The Company
hereby agrees to extend the benefits of this Agreement to any Holder of
Registrable Securities and any such Holder may specifically enforce the
provisions of this Agreement as if an original party hereto.

     (f)  Counterparts.  This Agreement may be executed in any number of
counterparts and by the parties hereto in separate counterparts, each of which
when so executed shall be deemed to be an original and all of which taken
together shall constitute one and the same agreement.

     (g)  Headings.  The headings in this agreement are for convenience of
reference only and shall not limit or otherwise affect the meaning hereof.

     (h)  Governing Law.  This agreement shall be governed by and construed in
accordance with the laws of the State of New York, without giving effect to any
provisions relating to conflicts of laws.

     (i)  Severability.  In the event that any one or more of the provisions
contained herein, or the application thereof in any circumstances, is held
invalid, illegal or unenforceable in any respect for any reason, the validity,
legality and enforceability of any such provision in every

                                      -17-
<PAGE>

other respect and of the remaining provisions hereof shall not be in any way
impaired or affected thereby, it being intended that all of the rights and
privileges of the parties hereto shall be enforceable to the fullest extent
permitted by law.

                                      -18-
<PAGE>

     Please confirm that the foregoing correctly sets forth the agreement
between the Company and you.

                                                  Very truly yours,

                                                  COR THERAPEUTICS, INC.

                                                  By: /s/ Vaughn M. Kailian
                                                     -------------------------
                                                     Name: Vaughn M. Kailian
                                                     Title: President and Chief
                                                            Executive Officer

The foregoing Registration Rights Agreement is hereby confirmed and accepted as
of the date first above written.

Goldman, Sachs & Co.,
Robertson Stephens, Inc.
Credit Suisse First Boston Corporation
CIBC World Markets Corp.
Needham & Company, Inc.

By: /s/ Goldman, Sachs & Co.
   ----------------------------
     (Goldman, Sachs & Co.)

                                      -19-
<PAGE>

                                                                      Appendix A

                            COR THERAPEUTICS, INC.

                        INSTRUCTION TO DTC PARTICIPANTS
                        -------------------------------

                               (Date of Mailing)

                    URGENT - IMMEDIATE ATTENTION REQUESTED

                        DEADLINE FOR RESPONSE:  [DATE]
                         ------------------------------

      The Depository Trust Company ("DTC") has identified you as a DTC
Participant through which beneficial interests in the COR Therapeutics, Inc.
(the "Company") 4.50% Convertible Senior Notes due June 15, 2006 (the "Notes")
are held.  The Notes are identified by CUSIP No. 217753 AE 2.

      In accordance with the terms of the Registration Rights Agreement, dated
as of June 11, 2001, between the Company and the Purchasers named therein (the
"Registration Rights Agreement"), the Company is in the process of registering
the Notes and the shares of common stock, par value $.0001 per share (together,
the "Securities"), issuable upon conversion thereof, under the Securities Act of
1933, as amended, for resale by the beneficial owners thereof.  In order to have
their Securities included in the registration statement, the beneficial owners,
INCLUDING BENEFICIAL OWNERS RESIDENT OUTSIDE THE UNITED STATES, must complete
and return the enclosed Notice of Registration Statement and Selling
Securityholder Questionnaire (the "Notice and Questionnaire").

      It is important that beneficial owners of the Securities receive a copy of
      --------------------------------------------------------------------------
the enclosed materials as soon as possible as their rights to have the
------------------------------------------
Securities included in the registration statement depend upon their returning
the Notice and Questionnaire by [DEADLINE FOR RESPONSE].  Please forward a copy
                                 ---------------------
of the enclosed documents to each beneficial owner that holds interests in the
Securities through you.  If you require more copies of the enclosed materials or
have any questions pertaining to this matter, please contact:

          COR Therapeutics, Inc.
          256 East Grand Avenue
          South San Francisco, California 94080
          Attention: Corporate Counsel
          Telephone: (650) 246-7315
          Fax: (650) 244-9208.
<PAGE>

                        NOTICE OF REGISTRATION STATEMENT
                    AND SELLING SECURITYHOLDER QUESTIONNAIRE
<PAGE>

                             COR Therapeutics, Inc.

                        Notice of Registration Statement
                                      and
                      Selling Securityholder Questionnaire
                                     (Date)

     COR Therapeutics, Inc. (the "Company") has filed or intends shortly to file
with the United States Securities and Exchange Commission (the "Commission") a
preliminary registration statement on Form S-3 (the "Shelf Registration
Statement") for the registration and resale under the United States Securities
Act of 1933, as amended (the "Securities Act"), of the Company's 4.50%
Convertible Senior Notes due June 15, 2006 (CUSIP No. 217753 AE 2) (the
"Notes"), and Common Stock issuable upon conversion thereof, in accordance with
the terms of the Registration Rights Agreement, dated as of June 11, 2001 (the
"Registration Rights Agreement"), between the Company and the purchasers named
therein (the "Purchasers").  A copy of the Registration Rights Agreement has
been sent to each of the Purchasers.  All capitalized terms not otherwise
defined herein shall have the meanings ascribed thereto in the Registration
Rights Agreement.

     In order to have Registrable Securities included in the Shelf Registration
Statement (or a supplement or amendment thereto), this Notice of Registration
Statement and Selling Securityholder Questionnaire ("Notice and Questionnaire")
must be completed, executed and delivered to the Company at the address set
forth herein for receipt ON OR BEFORE [insert date that is 25 days from the
Notice date] (the "Questionnaire Deadline").  Unless the Company otherwise
consents, beneficial owners of the Registrable Securities who do not complete,
execute and return this Notice and Questionnaire by such date (i) will not be
named as selling securityholders in the Shelf Registration Statement (or a
supplement or amendment thereto) and related Prospectus and (ii) may not sell
their Registrable Securities pursuant thereto.  Beneficial owners of Registrable
Securities not who have returned a Notice and Questionnaire by the Questionnaire
Deadline may, however, receive another Notice and Questionnaire from the Company
upon request.  Following its receipt of a completed and signed Notice and
Questionnaire, the Company will include the Registrable Securities covered
thereby in the Shelf Registration Statement subject to restrictions on the
timing and number of supplements to the Shelf Registration Statement provided in
the Registration Rights Agreement.

     Certain legal consequences arise from being named as a selling
securityholder in the Shelf Registration Statement and related Prospectus.
Accordingly, holders and beneficial owners of Registrable Securities are advised
to consult their own securities law counsel regarding the consequences of being
named or not being named as a selling securityholder in the Shelf Registration
Statement and related Prospectus.

     The term "Registrable Securities" is defined in the Registration Rights
Agreement to mean all or any portion of the Notes issued under the Trust
Indenture and the Common Stock issuable upon conversion of such Notes, provided,
however, that a security ceases to be a Registrable Security when it is no
longer a Restricted Security.
<PAGE>

     The term "Restricted Security" is defined in the Registration Rights
Agreement to mean any Note or Common Stock issuable upon conversion thereof
except any such Note or Common Stock which (i) has been registered pursuant to
an effective registration statement under the Securities Act and sold in a
manner contemplated by the Shelf Registration Statement, (ii) has been
transferred in compliance with Rule 144 under the Securities Act (or any
successor provision thereto) or is transferable pursuant to paragraph (k) of
Rule 144 (or any successor provision thereto) or (iii) has otherwise been
transferred and a new Note or share of Common Stock not subject to transfer
restrictions under the Securities Act has been delivered by or on behalf of the
Company in accordance with the Indenture.

                                    ELECTION

     The undersigned holder (the "Selling Securityholder") of Registrable
Securities hereby elects to include in the Shelf Registration Statement the
Registrable Securities beneficially owned by it and listed below in Item (3)
(unless otherwise specified under Item 3).  The undersigned, by signing and
returning this Notice and Questionnaire, agrees to be bound with respect to such
Registrable Securities by the terms and conditions of this Notice and
Questionnaire and the Registration Rights Agreement, including, without
limitation, Section 5 of the Registration Rights Agreement, as if the
undersigned Selling Securityholder were an original party thereto.

     Upon any sale of Registrable Securities pursuant to the Shelf Registration
Statement, the Selling Securityholder will be required to deliver to the Company
and the Trustee the Notice of Transfer (completed and signed) set forth in
Exhibit 1 attached to this Notice and Questionnaire and hereby undertakes to do
so.

     The Selling Securityholder hereby provides the following information to the
Company and represents and warrants that such information is accurate and
complete:
<PAGE>

                                 QUESTIONNAIRE

(1)  (a)  Full Legal Name of Selling Securityholder.

          ______________________________________________________________________

     (b)  Full Legal Name of Registered Holder (if not the same as in (a) above)
          of Registrable Securities Listed in (3) Below:
          ______________________________________________________________________

     (c)  Full Legal Name of Registered Holder (if applicable and if not the
          same as (b) above) Through Which Registrable Securities Listed in (3)
          Below are Held:
          ______________________________________________________________________

(2)  Address for Notices to Selling Securityholder:
     ___________________________________________________________________________
     ___________________________________________________________________________
     ___________________________________________________________________________
     Telephone:_________________________________________________________________

     Fax:_______________________________________________________________________

     Contact:___________________________________________________________________

(3)  Beneficial Ownership of Registrable Securities:

     Except as set forth below, the undesigned Selling Securityholder does not
     beneficially own any Notes or Common Stock previously issued upon
     conversion, repurchase or redemption of any Note.

     Principal amount of Notes beneficially owned:______________________________

     Number of shares of Common Stock beneficially owned and issued to date upon
     conversion, repurchase or redemption of Notes (if any):____________________

     Principal amount of Notes which the undersigned wishes to be included in
     the Shelf Registration Statement:__________________________________________

     Number of shares of Common Stock (if any) issued upon conversion,
     repurchase or redemption of Registrable Securities which are to be included
     in the Shelf Registration Statement:

     ___________________________________________________________________________

(4)  Other shares of Common Stock or other Notes of the Company owned by the
     Selling Securityholder:____________________________________________________

<PAGE>

     Except as set forth below, and under item (3) above, the undersigned
     Selling Securityholder is not the beneficial or registered owner of any
     shares of Common Stock or any other securities of the Company.

State any exceptions here:

(5)  Relationships with the Company:

     Except as set forth below, neither the Selling Securityholder nor any of
     its affiliates, officers, director or principal equity holders (5% or more)
     has held any position or office or has had any other material relationship
     with the Company (or its predecessors or affiliates) during the past three
     years.

State any exceptions here:

(6)  Plan of Distribution:

     Except as set forth below, the undersigned Selling Securityholder intends
     to distribute the Registrable Securities listed above in Item (3) only as
     follows (if at all): Such Registrable Securities may be sold from time to
     time directly by the undersigned Selling Securityholder or, alternatively,
     through underwriters, broker-dealers or agents.  Such Registrable
     Securities may be sold in one or more transactions at fixed prices, at
     prevailing market prices at the time of sale, at varying prices determined
     at the time of sale, or at negotiated prices.  Such sales may be effected
     in transactions (which may involve crosses or block transactions) (i) on
     any national securities exchanges or U.S. inter-dealer quotation system of
     a registered national securities association on which the Registrable
     Securities may be listed or quoted at the time of sale, (ii) in the over-
     the-counter market, (iii) in transactions otherwise than on such exchanges
     or services or in the over-the-counter market, or (iv) through the writing
     of options.  In connection with sales of the Registrable Securities or
     otherwise, the Selling Securityholder may enter into hedging transactions
     with broker-dealers, which may in turn engage in short sales of the
     Registrable Securities in the course of hedging the positions they assume.
     The Selling Securityholders may also sell Registrable Securities short and
     deliver Registrable Securities to close out such short positions, or loan
     or pledge Registrable Securities to broker-dealers that in turn may sell
     such securities.

State any exceptions here:

                                      -2-

<PAGE>

     Note:  In no event may such method(s) of distribution take the form of an
underwritten offering of the Registrable Securities without the prior agreement
of the Company.

     By signing below, the Selling Securityholder acknowledges that it
understands its obligation to comply, and agrees that it will comply, with the
prospectus delivery and other provisions of the Securities Act and Exchange Act
and the respective rules and regulations thereunder, particularly Regulation M.

     In the event that the Selling Securityholder transfers all or any portion
of the Registrable Securities listed in Item (3) above after the date on which
such information is provided to the Company, the Selling Securityholder agrees
to notify the transferee(s) at the time of the transfer of its rights and
obligations under this Notice and Questionnaire and the Registration Rights
Agreement.

     By signing below, the Selling Securityholder consents to the disclosure of
the information contained herein in its answers to Items (1) through (6) above
and the inclusion of such information in the Shelf Registration Statement and
related Prospectus.  The Selling Securityholder understands that such
information will be relied upon by the Company in connection with the
preparation of the Shelf Registration Statement and related Prospectus.

     In accordance with the Selling Securityholder's obligation under the
Registration Rights Agreement to provide such information as may be required by
law for inclusion in the Shelf Registration Statement, the Selling
Securityholder agrees to promptly notify the Company of any inaccuracies or
changes in the information provided herein which may occur subsequent to the
date hereof at any time while the Shelf Registration Statement remains in
effect.  All notices hereunder and pursuant to the Registration Rights Agreement
shall be made in writing by hand delivery, first-class mail, or air courier
guaranteeing overnight delivery as follows:

     To the Company:

          COR Therapeutics, Inc.
          256 East Grand Avenue
          South San Francisco, California 94080
          Attention: General Counsel

     Once this Notice and Questionnaire is executed by the Selling
Securityholder and received by the Company, the terms of this Notice and
Questionnaire, and the representations and warranties contained herein, shall be
binding on, shall inure to the benefit of and shall be enforceable by the
respective successors, heirs, personal representatives, and assigns of the
Company and the Selling Securityholder with respect to the Registrable
Securities beneficially owned by such Selling Securityholder and listed in Item
(3) above.  This Agreement shall be governed in all respects by the laws of the
State of New York.

                                      -3-
<PAGE>

     IN WITNESS WHEREOF, the undersigned, by authority duly given, has caused
this Notice and Questionnaire to be executed and delivered either in person or
by its duly authorized agent.

Dated:_________________________________________

      _________________________________________
      Selling Securityholder
      (Print/type full legal name of beneficial
      owner of Registrable Securities)

      By: _______________________________

      Name:______________________________

      Title:_____________________________

                                      -4-
<PAGE>

     PLEASE RETURN THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE FOR
RECEIPT ON OR BEFORE [DEADLINE FOR RESPONSE] TO THE COMPANY AT:

          COR Therapeutics, Inc.
          256 East Grand Avenue
          South San Francisco, California  94080
          Attention: General Counsel
<PAGE>

                                                                       EXHIBIT 1
                                                                   to Appendix A

             NOTICE TO TRANSFER PURSUANT TO REGISTRATION STATEMENT

Firstar Bank, N.A.
101 E. 5th Street
12th Floor Corporate Trust
St. Paul, MN  55101

COR Therapeutics, Inc.
256 East Grand Avenue
South San Francisco, California  94080
Attention:  General Counsel

Re:      4.50% Convertible Senior Notes due June 15, 2006 (the "Notes")

Dear Sirs:

     Please be advised that                                     has transferred
$      aggregate principal amount of the above-referenced Notes or shares of the
Company's Common Stock, issued on conversion, repurchase or redemption of Notes,
pursuant to the Registration Statement Form S-3 (File No. 333-    ) filed by the
Company.

     We hereby certify that the prospectus delivery requirements, if any, of the
Securities Act of 1933, as amended, have been satisfied with respect to the
transfer described above and that the above-named beneficial owner of the Notes
or Common Stock is named as a selling securityholder in the Prospectus dated or
in amendments or supplements thereto, and that the aggregate principal amount of
the Notes or number of Common Stock transferred are [a portion of] the Notes or
Common Stock listed in such Prospectus as amended or supplemented opposite such
owner's name.
<PAGE>

Dated: _______________________________  Very truly yours,

                              _________________________________________
                                             (Name)

                              By:______________________________________
                                         (Authorized Signature)<PAGE>

                                                                     EXHIBIT 4.3

                                AgraQuest, Inc.

                          FOURTH AMENDED AND RESTATED
                          INVESTORS' RIGHTS AGREEMENT

          This Fourth Amended And Restated Investors' Rights Agreement is made
as of the 11th day of December, 2000, by and among AgraQuest, Inc., a Delaware
corporation (the "Company"), the investors listed on Schedule A hereto (each an
                                                     ----------
"Investor," and collectively the "Investors"), Silicon Valley Bank and MMC/GATX
Partnership No. 1 (the "Warrant Holders"), Pamela G. Marrone, Duane Ewing, and
Bruce Holm (each a "Founder" and collectively the "Founders").

                                R E C I T A L S

          WHEREAS, certain Investors entered into a Series F Preferred Stock
Purchase Agreement with the Company as of the date hereof (the "Series F
Agreement");

          WHEREAS, certain Investors entered into a Series E Preferred Stock
Purchase Agreement with the Company (the "Series E Agreement");

          WHEREAS, certain Investors previously entered into a Series D
Preferred Stock Purchase Agreements with the Company (the "Series D Agreements")

          WHEREAS, certain Investors previously entered into Series C Preferred
Stock Purchase Agreements with the Company (the "Series C Agreements");

          WHEREAS, certain Investors previously entered into Series B Preferred
Stock Purchase Agreements with the Company (the "Series B Agreements");

          WHEREAS, certain Investors previously executed the Third Amended and
Restated Investors' Rights Agreement dated April 14, 2000 with the Company (the
"Prior Investors' Agreement") and this Agreement is meant to amend and restate
the Prior Investors' Agreement;

          WHEREAS, the Company may sell and issue additional shares of the
Series F Preferred Stock (the "Additional Series F Shares") to certain Investors
and other investors (the "Additional Series F Investors") pursuant to the Series
F Agreement or an Addendum to the Series F Preferred Stock Purchase Agreement to
be entered into between the Company and such Additional Series F Investors
(together with the Series F Agreement, the "Series F Agreement"); and

          WHEREAS, in order to induce the Company to enter into the Series F
Agreement and to induce the certain Investors to invest funds in the Company
pursuant to the Series F Agreement, the Investors, the Company, and the Founders
hereby agree that this Agreement shall

                                       1
<PAGE>

govern the rights of the Investors, the Founders, and the Warrant Holders to
cause the Company to register shares of Common Stock held by the Founders and
issuable to the Investors and the Warrant Holders and certain other matters as
set forth herein;

     NOW, THEREFORE, THE PARTIES HEREBY AGREE AS FOLLOWS:

     1.   Registration Rights.  The Company covenants and agrees as follows:

          1.1. Definitions.  For purposes of this Section 1:

               (a)  The term "Act" means the Securities Act of 1933, as amended,
and the rules and regulations promulgated thereunder.

               (b)  The term "Form S-3" means Form S-3 under the Act as in
effect on the date hereof or any registration form under the Act subsequently
adopted by the SEC which permits inclusion or incorporation of substantial
information by reference to other documents filed by the registrant with the
SEC.

               (c)  The term "Holder" means any person owning or having the
right to acquire Registrable Securities or any assignee thereof in accordance
with Section 1.12 hereof.

               (d)  The term "MMC" means MMC/GATX Partnership No. 1, or its
permitted assignee under the terms of the MMC Series C Warrant.

               (e)  The term "MMC Series C Warrant" means that Warrant dated
December 23, 1998, issued to MMC representing the right to purchase up to
thirty-one thousand two hundred (31,200) shares of the Series C Preferred Stock
of the Company.

               (f)  The term "1934 Act" shall mean the Securities Exchange Act
of 1934, as amended, and the rules and regulations promulgated thereunder.

               (g)  The term "Preferred Stock" means the Series B Preferred
Stock, the Series C Preferred Stock, the Series D Preferred Stock, the Series E
Preferred Stock and the Series F Preferred Stock.

               (h)  The terms "register," "registered," and "registration" refer
to a registration effected by preparing and filing a registration statement or
similar document in compliance with the Act, and the declaration or ordering of
effectiveness of such registration statement or document.

               (i)  The term "Registrable Securities" means (i) the Common Stock
issuable or issued upon conversion of Series B Preferred Stock, Series C
Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F
Preferred Stock; (ii) the two million one hundred seventy-two thousand four
hundred (2,172,400) shares of Common Stock (subject to appropriate adjustment
for stock splits, stock dividends, combinations and other recapitalizations
after the date hereof (collectively, a "Recapitalization")) issued or issuable
to the Founders of the Company in the amounts set forth on Schedule B attached
                                                           ----------
hereto; provided,

                                       2
<PAGE>

however that such shares of Common Stock issued or issuable to the Founders
shall not be deemed Registrable Securities and that the Founders, in connection
with such shares, shall not be deemed Holders for purposes of Sections 1.2,
1.15, and 3.9, (iii) the thirty one thousand two hundred (31,200) shares of
Common Stock (subject to appropriate adjustment for any Recapitalization)
issuable upon conversion of the Series C Preferred Stock issued or issuable to
MMC upon exercise of the MMC Series C Warrant and the seven thousand eight
hundred (7,800) shares of Common Stock (subject to appropriate adjustment for
any Recapitalization) issuable upon conversion of the Series C Preferred Stock
issued or issuable to SVB upon exercise of the SVB Series C Warrant; provided,
however, that such shares of Common Stock issued or issuable to MMC shall not be
deemed Registrable Securities and that MMC, in connection with such shares,
shall not be deemed a Holder for the purposes of Sections 1.2, 1.15, Section 2,
Section 3, or Section 3.9; and that such shares of Common Stock held by SVB
shall not be deemed Registrable Securities and that SVB, in connection with such
shares, shall not be deemed a Holder for purposes of Section 1.2, 1.12 and 1.15,
Section 2, Section 3, or Section 3.9; and (iv) any Common Stock of the Company
issued as (or issuable upon the conversion or exercise of any warrant, right or
other security which is issued as) a dividend or other distribution with respect
to, or in exchange for or in replacement of the shares referenced in clauses
(i), (ii) and (iii) above; provided, however, that any Common Stock issuable
under this clause (iv) shall not be deemed Registrable Securities and that any
holder of such Common Stock shall not be deemed a Holder for purposes of any
section of the Agreement for which the corresponding shares referenced in
clauses (ii) and (iii) above are not deemed Registrable Securities; excluding in
all cases, however, any shares that have been sold by a person in a transaction
in which his or her rights under this Section 1 are not assigned or that have
been sold by a person pursuant to a registration statement under the Act
covering such Registrable Securities that has been declared effective by the
SEC.

               (j)  The number of shares of "Registrable Securities then
outstanding" shall be determined by the number of shares of Common Stock
outstanding which are, and the number of shares of Common Stock issuable
pursuant to then exercisable or convertible securities which are, Registrable
Securities.

               (k)  The term "SEC" shall mean the Securities and Exchange
Commission and any successor thereto.

               (l)  The term "Series B Preferred Stock" shall mean the Series B
Preferred Stock of the Company sold pursuant to the terms of the Series B
Agreements.

               (m)  The term "Series C Preferred Stock" shall mean the Series C
Preferred Stock of the Company sold pursuant to the terms of the Series C
Agreements.

               (n)  The term "Series D Preferred Stock" shall mean the Series D
Preferred Stock of the Company sold pursuant to the terms of the Series D
Agreements.

               (o)  The term "Series E Preferred Stock" shall mean the Series E
Preferred Stock of the Company sold pursuant to the terms of the Series E
Agreement.

                                       3
<PAGE>

               (p)  The term "Series F Preferred Stock" shall mean the Series F
Preferred Stock of the Company sold pursuant to the terms of the Series F
Agreement.

               (q)  The term "SVB" means Silicon Valley Bank, or its permitted
assignee pursuant to the terms of the SVB Series C Warrant.

               (p)  The term "SVB Series C Warrant" shall mean that Warrant
dated December 23, 1998, issued to Silicon Valley Bank representing the right to
purchase up to seven thousand eight hundred (7,800) shares of the Series C
Preferred Stock of the Company.

          1.2. Request for Registration.

               (a)  If the Company shall receive at any time after the earlier
of (i) November 15, 2002, or (ii) three (3) months after the effective date of
the first registration statement for a public offering of securities of the
Company (other than a registration statement relating either to the sale of
securities to employees of the Company pursuant to a stock option, stock
purchase or similar plan or a SEC Rule 145 transaction), a written request from
the Holders of thirty percent (30%) of the Registrable Securities then
outstanding that the Company file a registration statement under the Act
covering the registration of at least twenty-five percent (25%) of the
Registrable Securities then outstanding (or any lesser percent if the
anticipated aggregate offering price, net of underwriting discounts and
commissions, would exceed Seven Million Five Hundred Thousand Dollars
(7,500,000), then the Company shall:

                    (i)  within ten (10) days of the receipt thereof, give
written notice of such request to all Holders; and

                    (ii) use its best efforts to effect, as soon as practicable
after receipt of such request, the registration under the Act of all Registrable
Securities which the Holders request to be registered, subject to the
limitations of subsection 1.2(b), within twenty (20) days of the mailing of such
notice by the Company in accordance with Section 3.7.

               (b)  If the Holders initiating the registration request hereunder
("Initiating Holders") intend to distribute the Registrable Securities covered
by their request by means of an underwriting, they shall so advise the Company
as a part of their request made pursuant to subsection 1.2(a) and the Company
shall include such information in the written notice referred to in subsection
1.2(a). The underwriter will be selected by the Company and shall be reasonably
acceptable to a majority in interest of the Initiating Holders. In such event,
the right of any Holder to include his Registrable Securities in such
registration shall be conditioned upon such Holder's participation in such
underwriting and the inclusion of such Holder's Registrable Securities in the
underwriting (unless otherwise mutually agreed by a majority in interest of the
Initiating Holders and such Holder) to the extent provided herein. All Holders
proposing to distribute their securities through such underwriting shall
(together with the Company as provided in subsection 1.4(e)) enter into an
underwriting agreement in customary form with the underwriter or underwriters
selected for such underwriting. Notwithstanding any other provision of this
Section 1.2, if the underwriter advises the Initiating Holders in writing that
marketing factors require a limitation of the number of shares to be
underwritten, then the

                                       4
<PAGE>

Initiating Holders shall so advise all Holders of Registrable Securities which
would otherwise be underwritten pursuant hereto, and the number of shares of
Registrable Securities that may be included in the underwriting shall be
allocated among all Holders thereof, including the Initiating Holders, in
proportion (as nearly as practicable) to the amount of Registrable Securities of
the Company owned by each Holder; provided, however, that the number of shares
of Registrable Securities to be included in such underwriting shall not be
reduced unless all other securities are first entirely excluded from the
underwriting.

               (c)  Notwithstanding the foregoing, if the Company shall furnish
to Holders requesting a registration statement pursuant to this Section 1.2, a
certificate signed by the Chief Executive Officer of the Company stating that in
the good faith judgment of the Board of Directors of the Company, it would be
seriously detrimental to the Company and its stockholders for such registration
statement to be filed and it is therefore essential to defer the filing of such
registration statement, the Company shall have the right to defer taking action
with respect to such filing for a period of not more than one hundred twenty
(120) days after receipt of the request of the Initiating Holders; provided,
however, that the Company may not utilize this right more than once in any
twelve (12) month period.

               (d)  In addition, the Company shall not be obligated to effect,
or to take any action to effect, any registration pursuant to this Section 1.2:

                    (i)  after the Company has effected two (2) registrations
pursuant to this Section 1.2 and such registrations have been declared or
ordered effective; and

                    (ii) during the period starting with the date sixty (60)
days prior to the Company's good faith estimate of the date of filing of, and
ending on a date one hundred eighty (180) days after the effective date of, a
registration subject to Section 1.3 hereof; provided that the Company is
actively employing in good faith all reasonable efforts to cause such
registration statement to become effective.

          1.3. Company Registration.  If (but without any obligation to do so)
the Company proposes to register (including for this purpose a registration
effected by the Company for stockholders other than the Holders) any of its
stock or other securities under the Act in connection with the public offering
of such securities solely for cash (other than a registration relating solely to
the sale of securities to participants in a Company stock plan, a registration
on any form which does not include substantially the same information as would
be required to be included in a registration statement covering the sale of the
Registrable Securities or a registration in which the only Common Stock being
registered is Common Stock issuable upon conversion of debt securities which are
also being registered), the Company shall, at such time, promptly give each
Holder written notice of such registration. Upon the written request of each
Holder given within twenty (20) days after mailing of such notice by the Company
in accordance with Section 3.7, the Company shall, subject to the provisions of
Section 1.8, cause to be registered under the Act all of the Registrable
Securities that each such Holder has requested to be registered.

                                       5
<PAGE>

          1.4.  Obligations of the Company. Whenever required under this Section
1 to effect the registration of any Registrable Securities, the Company shall,
as expeditiously as reasonably possible:

                (a)  Prepare and file with the SEC a registration statement with
respect to such Registrable Securities and use its best efforts to cause such
registration statement to become effective and keep such registration statement
effective for a period of up to one hundred eighty (180) days or until the
distribution contemplated in the Registration Statement has been completed;
provided, however, that (i) such 180-day period shall be extended for a period
of time equal to the period the Holder refrains from selling any securities
included in such registration at the request of an underwriter of Common Stock
(or other securities) of the Company; and (ii) in the case of any registration
of Registrable Securities on Form S-3 that are intended to be offered on a
continuous or delayed basis, such 180-day period shall be extended, if
necessary, to keep the registration statement effective until all such
Registrable Securities are sold, provided that Rule 145, or any successor rule
under the Act, permits an offering on a continuous or delayed basis, and
provided further that applicable rules under the Act governing the obligation to
file a post-effective amendment permit, in lieu of filing a post-effective
amendment that (I) includes any prospectus required by Section 10(a)(3) of the
Act or (II) reflects facts or events representing a material or fundamental
change in the information set forth in the registration statement, the
incorporation by reference of information required to be included in (I) and
(II) above to be contained in periodic reports filed pursuant to Section 13 or
15(d) of the Exchange Act in the registration statement.

                (b)  Prepare and file with the SEC such amendments and
supplements to such registration statement and the prospectus used in connection
with such registration statement as may be necessary to comply with the
provisions of the Act with respect to the disposition of all securities covered
by such registration statement.

                (c)  Furnish to each Holder such numbers of copies of a
prospectus, including a preliminary prospectus, in conformity with the
requirements of the Act, and such other documents as it may reasonably request
from time to time in order to facilitate the disposition of Registrable
Securities owned by it.

                (d)  Use its best efforts to register and qualify the securities
covered by such registration statement under such other securities or Blue Sky
laws of such jurisdictions as shall be reasonably requested by the Holders;
provided that the Company shall not be required in connection therewith or as a
condition thereto to qualify to do business or to file a general Consent to
service of process in any such states or jurisdictions, unless the Company is
already required to qualify to do business or subject to service in such
jurisdiction and except as may be required by the Act.

                (e)  In the event of any underwritten public offering, enter
into and perform its obligations under an underwriting agreement, in usual and
customary form, with the managing underwriter of such offering. Each Holder
participating in such underwriting shall also enter into and perform its
obligations under such an agreement.

                                       6
<PAGE>

                (f)  Notify each Holder of Registrable Securities covered by
such registration statement at any time when a prospectus relating thereto is
required to be delivered under the Act of the happening of any event as a result
of which the prospectus included in such registration statement, as then in
effect, includes an untrue statement of a material fact or omits to state a
material fact required to be stated therein or necessary to make the statements
therein not misleading in the light of the circumstances then existing.

                (g)  Cause all such Registrable Securities registered pursuant
hereunder to be listed on each securities exchange on which similar securities
issued by the Company are then listed.

                (h)  Provide a transfer agent and registrar for all Registrable
Securities registered pursuant hereunder and a CUSIP number for all such
Registrable Securities, in each case not later than the effective date of such
registration.

                (i)  make available for inspection by any Holder participating
in such registration, holding, in the aggregate, at least five percent (5%) of
the Registrable Securities(subject to appropriate adjustment for any
Recapitalization), any underwriter participating in any disposition pursuant to
such registration, and any attorney or accountant retained by any such Holder or
underwriter, all financial and other records, pertinent corporate documents and
properties of the Company, and cause the Company's officers and directors to
supply all information reasonably requested by any such Holder, underwriter,
attorney or accountant in connection with such registration statement; provided,
however, that such Holder, underwriter, attorney or accountant shall agree to
hold in confidence and trust all information so provided.

                (j)  make available to each Holder participating in such
registration, upon the request of such Holder:

                     (i)    in the case of an underwritten public offering, a
copy of any opinion of counsel for the Company provided to the underwriters
participating in such offering, dated the date such shares are delivered to such
underwriters for sale in connection with the registration statement;

                     (ii)   in the case of an underwritten public offering, a
copy of any "comfort" letters provided to the underwriters participating in such
offering and signed by the Company's independent public accountants who have
examined and reported on the Company's financial statements included in the
registration statement, to the extent permitted by the standards of the AICPA or
other relevant authorities; and

                     (iii)  a copy of all documents filed with and all
correspondence from or to the SEC in connection with any such offering other
than non-substantive cover letters and the like.

                (k)  otherwise use its best efforts to comply with all
applicable rules and regulations of the SEC, and make available to its security
holders, as soon as reasonably

                                       7
<PAGE>

practicable, an earnings statement covering the period of at least twelve (12)
months, but not more than eighteen (18) months, beginning with the first month
after the effective date of the Registration Statement, which earnings statement
shall satisfy the provisions of Section 11(a) of the Act.

          1.5.  Furnish Information.

                (a)  It shall be a condition precedent to the obligations of the
Company to take any action pursuant to this Section 1 with respect to
Registrable Securities of any selling Holder that such Holder shall furnish to
the Company such information regarding itself, the Registrable Securities held
by it, and the intended method of disposition of such securities as shall be
required to effect the registration of such Holder's Registrable Securities.

                (b)  The Company shall have no obligation with respect to any
registration requested pursuant to Section 1.2 or 1.16 if, due to the operation
of subsection 1.5(a), the number of shares or the anticipated aggregate offering
price of the Registrable Securities to be included in the registration does not
equal or exceed the number of shares or the anticipated aggregate offering price
required to originally trigger the Company's obligation to initiate such
registration as specified in subsection 1.2(a) or 1.16(a).

          1.6.  Expenses of Demand Registration. The Company shall bear and pay
all expenses, other than underwriting discounts and commissions relating to
Registrable Securities, incurred in connection with any registration, filing or
qualification of Registrable Securities with respect to the registrations
pursuant to Section 1.2 for each Holder, including (without limitation) all
registration, filing and qualification fees, printers' and accounting fees
relating or apportionable thereto and the fees and disbursements of one counsel
to the selling Holders hereunder (which counsel shall be designated by Holders
owning a plurality of the Registrable Securities, excluding any Registrable
Securities owned by any Founder or his or her transferees); provided, however,
that the Company shall not be required to pay for any expenses of any
registration proceeding begun pursuant to Section 1.2 if the registration
request is subsequently withdrawn at the request of the Holders of a majority of
the Registrable Securities to be registered (in which case all participating
Holders shall bear such expenses), unless either (a) such withdrawal by such
Holders is based upon a material adverse change in the condition, business or
prospects of the Company that was not known or communicated to the Holders
requesting registration at the time of their request for registration under
Section 1.2 and have withdrawn the request with reasonable promptness following
disclosure by the Company of such material change or (b) the Holders of a
majority of the Registrable Securities agree to forfeit their right to one
demand registration pursuant to Section 1.2.

          1.7.  Expenses of Company Registration.  The Company shall bear and
pay all expenses incurred in connection with any registration, filing or
qualification of Registrable Securities with respect to the registrations
pursuant to Section 1.3 for each Holder (which right may be assigned as provided
in Section 1.12), including (without limitation) all registration, filing, and
qualification fees, printers and accounting fees relating or apportionable
thereto and the fees and disbursements of counsel for the Company in its
capacity as counsel to the selling Holders hereunder; if Company counsel does
not make itself available for this purpose, the

                                       8
<PAGE>

Company will pay the reasonable fees and disbursements of one counsel for the
selling Holders selected by them, but excluding underwriting discounts and
commissions relating to Registrable Securities.

          1.8.  Underwriting Requirements.  In connection with any offering
involving an underwriting of shares of the Company's capital stock, the Company
shall not be required under Section 1.3 to include any of the Holders'
securities in such underwriting unless they accept the terms of the underwriting
as agreed upon between the Company and the underwriters selected by it and then
only in such quantity as the underwriters determine in their sole discretion
will not jeopardize the success of the offering by the Company. If the total
amount of securities, including Registrable Securities, requested by
stockholders to be included in such offering exceeds the amount of securities
sold other than by the Company that the underwriters determine in their sole
discretion is compatible with the success of the offering, then the Company
shall be required to include in the offering only that number of such
securities, including Registrable Securities, which the underwriters determine
in their sole discretion will not jeopardize the success of the offering (the
securities so included to be apportioned pro rata among the selling stockholders
according to the total amount of securities entitled to be included therein
owned by each selling stockholder or in such other proportions as shall mutually
be agreed to by such selling stockholders; provided that there shall be no
reduction in the number of securities of any Holder that is not a Founder unless
all securities held by the Founders and their transferees and any other holders
of Common Stock (other than the Holders) are first withdrawn from the offering).
For purposes of the preceding parenthetical concerning apportionment, for any
selling stockholder which is a holder of Registrable Securities and which is a
partnership or corporation, the partners, retired partners and stockholders of
such holder, or the estates and family members of any such partners and retired
partners and any trusts for the benefit of any of the foregoing persons shall be
deemed to be a single "selling stockholder," and any pro-rata reduction with
respect to such "selling stockholder" shall be based upon the aggregate amount
of shares carrying registration rights owned by all entities and individuals
included in such "selling stockholder," as defined in this sentence.

          1.9.  Delay of Registration.  No Holder shall have any right to obtain
or seek an injunction restraining or otherwise delaying any such registration as
the result of any controversy that might arise with respect to the
interpretation or implementation of this Section 1.

          1.10. Indemnification.  In the event any Registrable Securities are
included in a registration statement under this Section 1:

                (a)  To the extent permitted by law, the Company will indemnify
and hold harmless each Holder, each officer and director of such Holder, any
underwriter (as defined in the Act) of such Holder and each person, if any, who
controls such Holder or underwriter within the meaning of the Act or the 1934
Act, against any losses, claims, damages, or liabilities (joint or several) to
which they may become subject under the Act, the 1934 Act or other federal or
state law, insofar as such losses, claims, damages, or liabilities (or actions
in respect thereof) arise out of or are based upon any of the following
statements, omissions or violations (collectively a "Violation"): (i) any untrue
statement or alleged untrue statement of a material

                                       9
<PAGE>

fact contained in such registration statement, including any preliminary
prospectus or final prospectus contained therein or any amendments or
supplements thereto, (ii) the omission or alleged omission to state therein a
material fact required to be stated therein, or necessary to make the statements
therein not misleading, or (iii) any violation or alleged violation by the
Company of the Act, the 1934 Act, any state securities law or any rule or
regulation promulgated under the Act, the 1934 Act or any state securities law;
and the Company will pay to each such Holder, underwriter or controlling person
any legal or other expenses reasonably incurred by them in connection with
investigating or defending any such loss, claim, damage, liability, or action;
provided, however, that the indemnity agreement contained in this subsection
1.10(a) shall not apply to (1) a Holder who is either an officer or director of
the Company at the time of the statement, omission or violation (a "Management
Holder") unless (A) such Management Holder has sold shares included in the
registration statement and (B) each Holder that is not a Management Holder has
first been fully indemnified and held harmless pursuant to this Section 1.10;
(2) amounts paid in settlement of any such loss, claim, damage, liability, or
action if such settlement is effected without the consent of the Company (which
consent shall not be unreasonably withheld); or (3) any such loss, claim,
damage, liability, or action to the extent that it arises out of or is based
upon a Violation which occurs in reliance upon and in conformity with written
information furnished expressly for use in connection with such registration by
any such Holder (including each officer and director of such Holder),
underwriter or controlling person.

                (b)  To the extent permitted by law, each selling Holder will
indemnify and hold harmless the Company, each of its directors, each of its
officers who has signed the registration statement, each person, if any, who
controls the Company within the meaning of the Act, any underwriter, any other
Holder selling securities in such registration statement, each officer and
director of any such other Holder and any controlling person of any such
underwriter or other Holder, against any losses, claims, damages, or liabilities
(joint or several) to which any of the foregoing persons may become subject,
under the Act, the 1934 Act or other federal or state law, insofar as such
losses, claims, damages, or liabilities (or actions in respect thereto) arise
out of or are based upon any Violation, in each case to the extent (and only to
the extent) that such Violation occurs in reliance upon and in conformity with
written information furnished by such Holder, or by an officer or director of
any such Holder expressly for use in connection with such registration; and each
such Holder will pay any legal or other expenses reasonably incurred by any
person intended to be indemnified pursuant to this subsection 1.10(b), in
connection with investigating or defending any such loss, claim, damage,
liability, or action; provided, however, that the indemnity agreement contained
in this subsection 1.10(b) shall not apply to amounts paid in settlement of any
such loss, claim, damage, liability or action if such settlement is effected
without the consent of the Holder, which consent shall not be unreasonably
withheld; provided, further, that, in no event shall any indemnity under this
subsection 1.10(b) exceed the gross proceeds from the offering received by such
Holder net of underwriters commissions and discounts.

                (c)  Promptly after obtaining actual knowledge of any third
party claim or action as to which it may seek indemnification under this Section
1.10, an indemnified party will, if a claim in respect thereof is to be made
against any indemnifying party under this Section 1.10, deliver to the
indemnifying party a written notice thereof and the indemnifying party shall
have the right to participate in, and, to the extent the indemnifying party so
desires,

                                       10
<PAGE>

jointly with any other indemnifying party similarly noticed, to assume the
defense thereof with counsel mutually satisfactory to the parties; provided,
however, that an indemnified party (together with all other indemnified parties
which may be represented without conflict by one counsel) shall have the right
to retain one separate counsel, with the fees and expenses to be paid by the
indemnifying party, if representation of such indemnified party by the counsel
retained by the indemnifying party would be inappropriate due to actual or
potential differing interests between such indemnified party and any other party
represented by such counsel in such proceeding. The failure to deliver written
notice to the indemnifying party within a reasonable time of the commencement of
any such action shall relieve such indemnifying party of any liability to the
indemnified party under this Section 1.10, if, and to the extent that, such
failure is prejudicial to such indemnifying party's ability to defend such
action, but the omission so to deliver written notice to the indemnifying party
will not relieve it of any liability that it may have to any indemnified party
otherwise than under this Section 1.10.

                (d)  If the indemnification provided for in this Section 1.10 is
held by a court of competent jurisdiction to be unavailable to an indemnified
party with respect to any loss, liability, claim, damage, or expense referred to
therein, then the indemnifying party, in lieu of indemnifying such indemnified
party hereunder, shall contribute to the amount paid or payable by such
indemnified party as a result of such loss, liability, claim, damage, or expense
(including, without limitation, legal and other expenses incurred by such
indemnified party in investigating or defending any such action or claim) in
such proportion as is appropriate to reflect the relative fault of the
indemnifying party on the one hand and of the indemnified party on the other in
connection with the statements or omissions that resulted in such loss,
liability, claim, damage, or expense as well as any other relevant equitable
considerations. The relative fault of the indemnifying party and of the
indemnified party shall be determined by reference to, among other things,
whether the untrue or alleged untrue statement of a material fact or the
omission to state a material fact relates to information supplied by the
indemnifying party or by the indemnified party and the parties' relative intent,
knowledge, access to information, and opportunity to correct or prevent such
statement or omission. Notwithstanding the provisions of this Section 1.10, no
Holder shall be required to contribute any amount or make any other payments
under this Agreement which in the aggregate exceed the net proceeds received by
such Holder from the offering covered by the applicable registration statement.

                (e)  Notwithstanding the foregoing, to the extent that the
provisions on indemnification and contribution contained in the underwriting
agreement entered into in connection with the underwritten public offering are
in conflict with the foregoing provisions, the provisions in the underwriting
agreement shall control.

                (f)  The obligations of the Company and Holders under this
Section 1.10 shall survive the completion of any offering of Registrable
Securities in a registration statement under this Section 1, and otherwise.

          1.11. Reports Under Securities Exchange Act of 1934.  With a view to
making available to the Holders the benefits of Rule 144 promulgated under the
Act and any other rule or regulation of the SEC that may at any time permit a
Holder to sell securities of the

                                       11
<PAGE>

Company to the public without registration or pursuant to a registration on Form
S-3, the Company agrees to:

                (a)  make and keep public information available, as those terms
are understood and defined in SEC Rule 144, at all times after ninety (90) days
after the effective date of the first registration statement filed by the
Company for the offering of its securities to the general public;

                (b)  take such action, including the voluntary registration of
its Common Stock under Section 12 of the 1934 Act, as is necessary to enable the
Holders to utilize Form S-3 for the sale of their Registrable Securities, such
action to be taken as soon as practicable after the end of the fiscal year in
which the first registration statement filed by the Company for the offering of
its securities to the general public is declared effective;

                (c)  file with the SEC in a timely manner all reports and other
documents required of the Company under the Act and the 1934 Act; and

                (d)  furnish to any Holder, so long as the Holder owns any
Registrable Securities, forthwith upon request (i) a written statement by the
Company that it has complied with the reporting requirements of SEC Rule 144 (at
any time after ninety (90) days after the effective date of the first
registration statement filed by the Company), the Act and the 1934 Act (at any
time after it has become subject to such reporting requirements), or that it
qualifies as a registrant whose securities may be resold pursuant to Form S-3
(at any time after it so qualifies), (ii) a copy of the most recent annual or
quarterly report of the Company and such other reports and documents so filed by
the Company, and (iii) such other information as may be reasonably requested in
availing any Holder of any rule or regulation of the SEC which permits the
selling of any such securities without registration or pursuant to such form.

          1.12. Assignment of Registration Rights.  The rights to cause the
Company to register Registrable Securities pursuant to this Section 1 may be
assigned (but only with all related obligations) by a Holder to a transferee or
assignee of such securities who, after such assignment or transfer, holds at
least forty thousand (40,000) shares of Registrable Securities (subject to
appropriate adjustment for any Recapitalization), and provided: (a) the Company
is, within a reasonable time after such transfer, furnished with written notice
of the name and address of such transferee or assignee and the securities with
respect to which such registration rights are being assigned; (b) such
transferee or assignee agrees in writing to be bound by and subject to the terms
and conditions of this Agreement, including without limitation the provisions of
Section 1.13 below; (c) such assignment shall be effective only if immediately
following such transfer the further disposition of such securities by the
transferee or assignee is restricted under the Act; and (d) MMC may assign such
registration rights to an affiliate or affiliates of MMC notwithstanding the
minimum number of shares otherwise required hereby. For the purposes of
determining the number of shares of Registrable Securities held by a transferee
or assignee, the holdings of transferees and assignees of a partnership who are
partners or retired partners of such partnership (including spouses and
ancestors, lineal descendants and siblings of such partners or spouses who
acquire Registrable Securities by gift, will or intestate succession) shall be
aggregated together and with the partnership; provided that all assignees and
transferees who

                                       12
<PAGE>

would not qualify individually for assignment of registration rights shall have
a single attorney-in-fact for the purpose of exercising any rights, receiving
notices or taking any action under this Section 1.

          1.13. "Market Stand-Off" Agreement.  Each Holder hereby agrees that,
during the period of duration specified by the Company and an underwriter of
common stock or other securities of the Company, following the effective date of
a registration statement of the Company filed under the Act, it shall not, to
the extent requested by the Company and such underwriter, directly or indirectly
sell, offer to sell, contract to sell (including, without limitation, any short
sale), grant any option to purchase or otherwise transfer or dispose of (other
than to donees who agree to be similarly bound) any securities of the Company
held by it at any time during such period except common stock included in such
registration; provided, however, that:

                (a)  such agreement shall be applicable only to the first two
(2)such registration statements of the Company which covers common stock (or
other securities) to be sold on its behalf to the public in an underwritten
offering;

                (b)  such market stand-off time period shall not exceed one
hundred eighty (180) days;

                (c)  such agreement shall not be applicable three (3) years
after the effective date of the first registration statement for a public
offering of securities of the Company; and

                (d)  all Founders and all officers and directors of the Company
enter into similar agreements.

          In order to enforce the foregoing covenant, the Company may impose
stop-transfer instructions with respect to the Registrable Securities of each
Holder (and the shares or securities of every other person subject to the
foregoing restriction) until the end of such period.

          Notwithstanding the foregoing, the obligations described in this
Section 1.13 shall not apply to a registration relating solely to employee
benefit plans on Form S-1 or Form S-8 or similar forms which may be promulgated
in the future, or a registration relating solely to a Commission Rule 145
transaction on Form S-4 or similar forms which may be promulgated in the future.

          1.14. Termination of Registration Rights.

                (a)  No Holder shall be entitled to exercise any right provided
for in this Section 1 after five (5) years following the consummation of the
sale of securities pursuant to a registration statement filed by the Company
under the Act in connection with the initial firm commitment underwritten
offering of its Common Stock to the general public.

                (b)  In addition, the right of any Holder to request
registration or inclusion in any registration pursuant to Section 1.3 shall
terminate on such date after the closing of the first Company-initiated
registered public offering of Common Stock of the Company as all

                                       13
<PAGE>

shares of Registrable Securities held or entitled to be held upon conversion by
such Holder may immediately be sold under Rule 144 during any ninety (90) day
period.

          1.15. Limitations on Registration Rights.  Except with respect to
Additional Series F Investors, from and after the date of this Agreement, the
Company, except with the prior written consent of the Holders of a majority of
the Registrable Securities then outstanding, shall not enter into any agreement
with any holder or prospective holder of any securities of the Company giving
such holder or prospective holder the right to require the Company, upon any
registration of any of its securities, to include, among the securities that the
Company is then registering, securities owned by such holder, unless under the
terms of such agreement, such holder or prospective holder may include such
securities in any such registration only to the extent that the inclusion of its
securities will not limit the number of Registrable Securities sought to be
included by the Holders of Registrable Securities.

          1.16. Registration on Form S-3.

                (a)  After its initial public offering, the Company shall use
its best efforts to qualify for registration on Form S-3 or any comparable or
successor form or forms. After the Company has qualified for the use of Form S-
3, in addition to the rights contained in the foregoing provisions of this
Section 1, the Holders of Registrable Securities shall have the right to request
registrations on Form S-3 (such requests shall be in writing and shall state the
number of shares of Registrable Securities to be disposed of and the intended
methods of disposition of such shares of such Holder or Holders); provided,
however, that the Company shall not be obligated to effect any such registration
if (i) the Holders, together with the holders of any other securities of the
Company entitled to inclusion in such registration, propose to sell Registrable
Securities and such other securities (if any) on Form S-3 at an aggregate price
to the public of less than One Million Dollars ($1,000,000) (net of any
underwriters' discounts or commissions), or (ii) in the event that the Company
shall furnish the certification described in Section 1.2(c) (but subject to the
limitations set forth therein), or (iii) in a given twelve (12) month period,
after the Company has effected one such registration in any such period, or (iv)
it is to be effected more than five (5) years after the Company's initial public
offering. The Company shall not be required to register in any jurisdiction in
which it would be required to qualify to do business or to execute a general
consent to service of process in effecting such registration.

                (b)  If a request complying with the requirements of Section
1.16(a) above is delivered to the Company, and the registration is for an
underwritten offering, the provisions of Section 1.2(b) hereof shall apply to
such registration.

                (c)  All expenses incurred in connection with four (4)
registrations requested pursuant to Section 1.16, including (without limitation)
all registration, filing, qualification, printer's and accounting fees and the
reasonable fees and disbursements of one counsel for the selling Holder or
Holders and counsel for the Company, shall be borne by the Company; thereafter
all expenses including fees and disbursements of all counsel for the selling
Holder or Holders and counsel for the Company shall be borne pro rata by the
Holder or Holders participating in the S-3 registration.

                                       14
<PAGE>

     2.   Covenants of the Company.

          2.1.  Financial Statements. Subject to the restrictions set forth in
this Section 2.1 below, the Company will furnish to Investors:

                (a)  As soon as available, but in every event not later than one
hundred twenty (120) days after the close of each fiscal year, a statement of
income and a statement of cash flows for such year, a statement of income and a
statement of cash flows for such fiscal year, a balance sheet and statement of
stockholders' equity as of the end of such year and complete notes to financial
statements, prepared in accordance with generally accepted accounting
principles, accompanied by a report of certified public accountants of
nationally recognized standing selected by the Board of Directors of the
Company.

                (b)  As soon as available, but in any event not later than
forty-five (45) days after the close of each fiscal quarter other than the
fourth quarter of a fiscal year, unaudited statements of income and cash flows
for such fiscal quarter and an unaudited balance sheet and unaudited statement
of stockholders' equity as of the end of such fiscal quarter, certified to be
correct by the President of the Company, subject to normal year-end adjustments.

                (c)  To each Investor holding, in the aggregate, at least four
hundred thousand (400,000) shares of Registrable Securities (subject to
appropriate adjustment for any Recapitalization) as soon as available, but in
any event within thirty (30) days after the end of each calendar month,
consolidated balance sheets of the Company and its subsidiaries, if any, as of
the end of such calendar month, and consolidated statements of income and cash
flows for such period and for the current fiscal year to date, together with a
comparison of such statements to the Company's operating plan then in effect.

                (d)  To each Investor holding, in the aggregate, at least four
hundred thousand (400,000) shares of Registrable Securities (subject to
appropriate adjustment for any Recapitalization) as soon as practicable upon
approval or adoption by the Company's Board of Directors, the Company's budget
and operating plan (including projected balance sheets and profits and loss and
cash flow statements) for each fiscal year.

          2.2.  Inspection. The Company shall permit each Holder of at least
four hundred thousand (400,000) shares of Registrable Securities (subject to
appropriate adjustment for any Recapitalization) to visit and inspect the
properties of the Company, including its corporate and financial records, and to
discuss its business and finances with the officers of the Company, during
normal business hours following reasonable notice and as often as may be
reasonably requested.

          2.3.  Key Employee Insurance. The Company shall maintain term life
insurance upon the life of Pamela Marrone in the minimum amount of One Million
Dollars ($1,000,000) with the proceeds payable to the Company.

          2.4.  Nondisclosure Agreements. The Company shall require all persons
now or hereafter employed by the Company or any subsidiary who have access to
confidential and proprietary information of the Company or any subsidiary to
enter into agreements containing

                                       15
<PAGE>

nondisclosure and assignment of invention provisions substantially in the form
attached as Exhibit E to the Series F Agreements. The Company shall require all
            ---------
consultants now or hereafter hired, consulted or retained by the Company or any
subsidiary who have access to confidential and proprietary information of the
Company or any subsidiary to enter into agreements containing nondisclosure
provisions substantially in the form attached as Exhibit F to the Series F
                                                 ---------
Agreements.

          2.5.  Right of First Refusal as to New Securities.

                (a)  The Company hereby grants to each Investor a right of first
refusal to purchase, on a pro rata basis, all or any part of the New Securities
(as defined below) that the Company may, from time to time, propose to sell and
issue, subject to the terms and conditions set forth below. For purposes of this
Section 2.5, an Investor shall mean any Investor who holds at least one hundred
thousand (100,000) shares of Registrable Securities (subject to appropriate
adjustment for any Recapitalization). An Investor's pro rata share for purposes
of this Section 2.5 shall equal a fraction, the numerator of which is the number
of shares of capital stock of the Company owned by such Investor and the
denominator of which is the total number of shares of capital stock of the
Company owned by all of the Investors.

          (b)   "New Securities" shall mean any capital stock of the Company
whether now authorized or not, and rights, options or warrants to purchase
capital stock, and securities of any type whatsoever that are, or may become,
convertible into or exchangeable for capital stock; provided, however, that the
term "New Securities" does not include (A) the Series F Preferred Stock issuable
under the Series F Agreements (including any amendment hereto) or the shares of
Common Stock issuable upon conversion thereof; (B) securities offered to the
public pursuant to a registration statement or document; (C) securities issued
for the acquisition of another corporation or division of a corporation by the
Company by merger, purchase of substantially all the assets of such corporation
or division or other reorganization resulting in the ownership by the Company of
not less than fifty-one percent (51%) of the voting power of such corporation;
(D) securities issued as a result of any stock split, stock dividend or
reclassification of Common Stock, distributable on a pro rata basis to all
holders of Common Stock; (E) the issuance of securities pursuant to the
conversion or exercise of convertible or exercisable securities; (F) a total of
not more than three million five hundred thousand (3,500,000) shares of Common
Stock issued to officers, directors, employees or consultants of the Company
pursuant to stock option plans of the Company (subject to appropriate adjustment
for any Recapitalization) and the related underlying options; (G) not more than
fifty thousand (50,000) shares of Common Stock issued, in each instance,
pursuant to the issuance of stock warrants or other securities or rights to
persons or entities with which the Company has business relationships, other
than officers, directors or employees of the Company, provided such issuances
are for other than primarily equity financing purposes; (H) any capital stock of
the Company's operating subsidiary engaged in the internet business named
NaturalAg.com. or such other name as the Company may decide whether now
authorized or not, and rights, options or warrants to purchase capital stock,
and securities of any type whatsoever that are, or may become, convertible or
exchangeable for capital stock; or (I) securities issued in connection with a
strategic alliance, joint venture, or licensing arrangement approved by the
Board of Directors, provided such issuances are for other than primarily equity
financing purposes.

                                       16
<PAGE>

                (c)  In the event the Company intends to issue New Securities,
it shall give each Investor written notice of such intention, describing the
type of New Securities to be issued, the price thereof and the general terms
upon which the Company proposes to effect such issuance. Each Investor shall
have twenty (20) days from the date of any such notice to agree to purchase all
or part of its pro rata share of such New Securities for the price and upon the
general terms and conditions specified in the Company's notice by giving written
notice to the Company stating the quantity of New Securities to be so purchased.
Each Investor shall have a right of over allotment such that if any Investor
fails to exercise its right hereunder to purchase its total pro rata portion of
the New Securities, the other Investors may purchase such portion on a pro rata
basis, by giving written notice to the Company within five (5) days from the
date that the Company provides written notice to the other Investors of the
amount of New Securities with respect to which such nonpurchasing Investor has
failed to exercise its rights hereunder.

                (d)  In the event any Investor fails to exercise the foregoing
right of first refusal with respect to any New Securities within such twenty
(20) day period (or the additional five (5) day period provided for over
allotments), the Company may within one hundred twenty (120) days thereafter
sell any or all of such New Securities not agreed to be purchased by the
Investors, at a price and upon general terms no more favorable to the purchasers
thereof than specified in the notice given to each Investor pursuant to
paragraph (c) above. In the event the Company has not sold such New Securities
within such one hundred twenty (120) day period, the Company shall not
thereafter issue or sell any New Securities without first offering such New
Securities to the Investors in the manner provided above.

          2.6.  Election of Directors.

                (a)  In the event that the Company incurs cumulative net losses
in excess of Seven Million Dollars ($7,000,000) calculated in accordance with
generally accepted accounting principles as reflected in the Company's quarterly
or annual financial statements (a "Default"), then commencing on the tenth day
following such Default and continuing thereafter until the date on which such
Default is cured, the Company shall use its best efforts to increase the size of
the Board of Directors such that a majority of the directors will be designated
by the Investors owning a majority in interest of the Preferred Stock held by
all Investors (the "Provisional Directors"), as discussed below. The Investors
shall be entitled to designate the Provisional Directors at any annual meeting
or special meeting called for such purpose or at any adjournment thereof. The
Company shall use its best efforts, and the Founders agree to vote their shares,
to accomplish such action as shall be required for the Investors to designate
and elect the Provisional Directors. For purposes of this Section 2.6(a), such
Default shall be cured only at such time that the Company has achieved a
cumulative operating profit with respect to the period commencing on and
continuing after the date that the Company first began operations, calculated in
accordance with generally accepted accounting principles as reflected in the
Company's quarterly or annual financial statements. Upon such cure each Investor
agrees to vote its shares to remove the Provisional Directors.

          (b)   In the event that, pursuant to Paragraph (B)(1) of Article IV of
the Company's Restated Certificate of Incorporation, (i) the Company offers to
purchase outstanding shares of Series F Preferred Stock, Series E Preferred
Stock, Series D Preferred Stock or Series

                                       17
<PAGE>

C Preferred Stock, or all of such Preferred Stock, and (ii) the holders of at
least twenty percent (20%) of the outstanding shares, previously issued by the
Company, of the respective and applicable series accept the offer, and the
Company fails (the "Failure") so to purchase such shares of the Series F
Preferred Stock, Series E Preferred Stock, Series D Preferred Stock or Series C
Preferred Stock as applicable (each, an "Affected Series"), the Company shall
use its best efforts to increase the size of the Board of Directors such that a
majority of the directors (the "Provisional Directors") may be designated by the
holders of all of the outstanding shares of the Affected Series as discussed
below. The holders of the shares of the Affected Series, shall be entitled to
designate the Provisional Directors at any annual meeting or special meeting
called for such purpose or at any adjournment thereof. The Company shall use its
best efforts, and the Founders and the Investors agree to vote their shares, to
accomplish such action as shall be required for the holders of the Affected
Series to designate and elect the Provisional Directors. For purposes of this
Section 2.6(b), such Failure shall be cured upon payment in full of those
amounts required to be paid (as of the date of such cure) as set forth in
Paragraph (B)(1) of Article IV of the Company's Restated Certificate of
Incorporation. Upon such cure each Investor agrees to vote its shares to remove
the Provisional Directors and to decrease the size of the Board of Directors to
the size that existed immediately prior to the date of the Failure.

          2.7.  Additional Equity Investment. The Company may form an operating
subsidiary for the business purpose of establishing an internet business to be
named NaturalAg.com, or such other name as the Company may decide (a
"Subsidiary"). In the event that the Subsidiary concludes an initial equity
financing in which the Subsidiary will receive at least $1,000,000 in aggregate
proceeds from outside investors (excluding any conversion of debt into equity)
(an "Initial Financing"), the Company will issue pro rata to the certain
Investors to the Series E Preferred Stock Purchase Agreement between the Company
and such investors dated April 14, 2000 (the "Series E Purchase Agreement')
warrants to purchase shares of the type of equity securities that are sold in
the Initial Financing (as defined in the Series E Purchase Agreement") equal to
up to 25% of the outstanding capital stock of the Subsidiary immediately
following the closing of the Initial Financing. The terms and conditions of the
shares of equity securities of the Subsidiary subject to the Warrants, including
the purchase price, shall be the same as the equity securities sold in the
Initial Financing. The Warrants will terminate upon the third anniversary of the
closing of the Initial Financing.

          2.8.  Negative Covenants.

                (a)  The Company shall not, so long as (i) not less than fifty
percent (50%) of the Series B Preferred Stock previously issued is still
outstanding, (ii) not less than fifty percent (50%) of the Series C Preferred
Stock previously issued is still outstanding (except in the case where an Offer
has been made and Notice of Acceptance given (as defined in Paragraph (B)(1) of
Article IV of the Company's Restated Certificate of Incorporation), then so long
as not less than twenty percent (20%) of the Series C Preferred Stock previously
issued by the Company is still outstanding), (iii) not less than fifty percent
(50%) of the Series D Preferred Stock previously issued is still outstanding
(except in the case where an Offer has been made and Notice of Acceptance given,
then twenty percent (20%) of the Series D Preferred Stock previously issued by
the Company is outstanding), (iv) not less than fifty percent (50%) of the
Series E Preferred Stock previously issued is still outstanding (except in the
case where an Offer

                                       18
<PAGE>

has been made and Notice of Acceptance given, then twenty percent (20%) of the
Series E Preferred Stock previously issued by the Company is outstanding), or
(v) not less than fifty percent (50%) of the Series F Preferred Stock previously
issued is still outstanding (except in the case where an Offer has been made and
Notice of Acceptance given, then twenty percent (20%) of the Series F Preferred
Stock previously issued by the Company is outstanding) without prior written
consent of the holders of not less than a majority of the then outstanding
shares of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred
Stock, Series E Preferred Stock and Series F Preferred Stock, voting together as
a single class:

                     (i)   Merge with or into or consolidate with any other
corporation, or sell, lease, or otherwise dispose of all or substantially all of
its properties or assets.

                     (ii)  Amend or repeal its Certificate of Incorporation.

                     (iii) With the exception of lines of credit that exist as
of the date hereof, permit to be outstanding any additional indebtedness,
capital lease obligations, or other long-term lease obligations created,
incurred or assumed on or after February 19, 1999 in excess of Five Hundred
Thousand Dollars ($500,000) in the aggregate.

                     (iv)  Redeem, purchase or otherwise acquire for value (or
pay into or set aside for sinking fund for such purpose) any share or shares of
Preferred Stock except pursuant to Paragraph (B)(1) of Article IV of the
Company's Restated Certificate of Incorporation.

                     (v)   Redeem, purchase or otherwise acquire (or pay into or
set aside for a sinking fund for such purpose) any shares of Common Stock;
provided, however, that this restriction shall not apply to the repurchase of
shares of Common Stock from employees, officers, directors, consultants or other
persons performing services for the Company or any subsidiary pursuant to
agreements under which the Company exercises its option to repurchase such
shares at cost.

                     (vi)  Without the prior unanimous approval of the Board of
Directors of the Company, enter into any transaction with any employee,
consultant, officer or director of the Company or holder of ten percent (10%) of
any class of capital stock of the Company, or any member of their respective
immediate families or any corporation or other entity directly or indirectly
controlled by one or more of such employees, consultants, officers, directors or
ten percent (10%) stockholders or members of their immediate families, on terms
less favorable to the Company than in would obtain in a transaction between
unrelated parties.

                     (vii) Effect any reverse stock split, stock combination,
reclassification or similar event.

                (b)  The Company shall not, so long as not less than fifty
percent (50%) of the Series F Preferred Stock previously issued is still
outstanding (except in the case where an Offer has been made and Notice of
Acceptance given (as defined in Paragraph (B)(1) of Article IV of the Company's
Restated Certificate of Incorporation), then so long as not less than twenty
percent (20%) of the Series F Preferred Stock previously issued by the Company
is still

                                       19
<PAGE>

outstanding), without prior written consent of the holders of not less than two-
thirds (2/3) of the then outstanding Series F Preferred Stock:

                     (i)   Authorize or issue any other class or series of stock
in preference over or on a parity with the Series F Preferred Stock or any
options, warrants or other rights to acquire any such class or series of stock.

                     (ii)  Declare or pay any dividend with respect to the
Common Stock unless a dividend in an amount no less per share than that declared
or paid with respect to the Common Stock is declared and paid with respect to
the Series F Preferred Stock.

                (c)  The Company shall not, so long as not less than fifty
percent (50%) of the Series E Preferred Stock previously issued is still
outstanding (except in the case where an Offer has been made and Notice of
Acceptance given (as defined in Paragraph (B)(1) of Article IV of the Company's
Restated Certificate of Incorporation), then so long as not less than twenty
percent (20%) of the Series E Preferred Stock previously issued by the Company
is still outstanding), without prior written consent of the holders of not less
than two-thirds (2/3) of the then outstanding Series E Preferred Stock:

                     (i)   Authorize or issue any other class or series of stock
in preference over or on a parity with the Series E Preferred Stock or any
options, warrants or other rights to acquire any such class or series of stock.

                     (ii)  Declare or pay any dividend with respect to the
Common Stock unless a dividend in an amount no less per share than that declared
or paid with respect to the Common Stock is declared and paid with respect to
the Series E Preferred Stock.

                (d)  The Company shall not, so long as not less than fifty
percent (50%) of the Series D Preferred Stock previously issued is still
outstanding (except in the case where an Offer has been made and Notice of
Acceptance given (as defined in Paragraph (B)(1) of Article IV of the Company's
Restated Certificate of Incorporation), then so long as not less than twenty
percent (20%) of the Series D Preferred Stock previously issued by the Company
is still outstanding), without prior written consent of the holders of not less
than two-thirds (2/3) of the then outstanding Series D Preferred Stock:

                     (i)   Authorize or issue any other class or series of stock
in preference over or on a parity with the Series D Preferred Stock or any
options, warrants or other rights to acquire any such class or series of stock.

                     (ii)  Declare or pay any dividend with respect to the
Common Stock unless a dividend in an amount no less per share than that declared
or paid with respect to the Common Stock is declared and paid with respect to
the Series D Preferred Stock.

                (e)  The Company shall not, so long as not less than fifty
percent (50%) of the Series C Preferred Stock previously issued is still
outstanding (except in the case where an Offer has been made and Notice of
Acceptance given (as defined in Paragraph (B)(1) of Article IV of the Company's
Restated Certificate of Incorporation), then so long as not less than twenty

                                       20
<PAGE>

percent (20%) of the Series C Preferred Stock previously issued by the Company
is still outstanding), without prior written consent of the holders of not less
than two-thirds (2/3) of the then outstanding Series C Preferred Stock:

                     (i)   Authorize or issue any other class or series of stock
in preference over or on a parity with the Series C Preferred Stock or any
options, warrants or other rights to acquire any such class or series of stock.

                     (ii)  Declare or pay any dividend with respect to the
Common Stock unless a dividend in an amount no less per share than that declared
or paid with respect to the Common Stock is declared and paid with respect to
the Series C Preferred Stock.

                (f)  The Company shall not, so long as not less than fifty
percent (50%) of the Series B Preferred Stock previously issued is still
outstanding, without prior written consent of the holders of not less than a
majority of the then outstanding Series B Preferred Stock:

                     (i)   Authorize or issue any other class or series of stock
in preference over or on a parity with the Series B Preferred Stock or any
options, warrants or other rights to acquire any such class or series of stock.

                     (ii)  Declare or pay any dividend with respect to the
Common Stock unless a dividend in an amount no less per share than that declared
or paid with respect to the Common Stock is declared and paid with respect to
the Series B Preferred Stock.

          2.9.  Confidentiality, Termination and Assignment of Certain
Covenants.

                (a)  Each Investor agrees that it will at all times keep
confidential and will not disclose or divulge, or use for any purpose other than
to evaluate its investment in the Company, any confidential, proprietary or
secret information which such Investor may obtain from the Company pursuant to
the Company's obligations to submit financial statements, reports and other
materials hereunder, or pursuant to visitation, inspection or management meeting
rights granted hereunder unless such information is or becomes known to the
Investor from a source other than the Company, is or becomes publicly known
other than as a result of a breach by such Investor of this Section 2.9, or
unless the Company gives its written consent to the Investor's release of such
information, except that no such written consent shall be required (and the
Investor shall be free to release such information) if such information is to be
provided to such Investor's counsel or accountant or other advisor, or to an
officer, director or partner of an Investor, provided that such Investor shall
inform the recipient of the confidential nature of such information, and shall
instruct the recipient to treat the information as confidential. The provisions
of this Section 2.9 shall be in addition to, and not in substitution for, the
provisions of any separate nondisclosure agreement executed by the parties
hereto, and shall survive the termination of this Agreement.

                (b) The covenants set forth in Section 2 (other than those
contained in Section 2.9(a) above) shall terminate and be of no further force or
effect upon the consummation

                                       21
<PAGE>

of the sale of securities pursuant to a registration statement filed by the
Company under the Act in connection with the firm commitment underwritten
offering of its securities to the general public.

                (c)  The rights to information set forth in Sections 2.1(a) and
2.1(b) may not be assigned or transferred to any third party who does not, after
such assignment or transfer, hold at least forty-thousand (40,000) of the
Registrable Securities (subject to appropriate adjustment for any
Recapitalization), except by each Holder to any wholly owned subsidiary or
parent of, or to any corporation or entity that is, within the meaning of the
Act, controlling, controlled by or under common control with, any such Holder
(other than to a direct competitor of the Company, as reasonably determined by
the Company).

                (d)  The rights to information and inspection set forth in
Sections 2.1(c), 2.1(d) and 2.2 may not be assigned or transferred to any third
party who does not, after such assignment or transfer, hold at least four
hundred thousand (400,000) shares of the Registrable Securities (subject to
appropriate adjustment for any Recapitalization), except by each Holder to any
wholly owned subsidiary or parent of, or to any corporation or entity that is,
within the meaning of the Act, controlling, controlled by or under common
control with, any such Holder (other than to a direct competitor of the Company,
as reasonably determined by the Company).

          2.10. Observer Rights. The Company shall permit each Holder of at
least four hundred thousand (400,000) shares of the Registrable Securities
(subject to appropriate adjustment for any Recapitalization) to appoint a
representative (the "Representative") to attend all meetings of the Board of
Directors of the Company in a nonvoting observer capacity (the "Observer
Rights") and, in this respect, shall give the Representative copies of all
notices to all meetings; provided, however, that such Holder hereby agrees for
itself and on behalf of the Representative to hold in confidence and trust and
to act in a fiduciary manner with respect to all information provided or
disclosed in such meetings; and provided further that the Company reserves the
right to withhold information and to exclude the Representative from any meeting
or portion thereof if access to such information or attendance at such meeting
could adversely affect the attorney-client privilege between the Company and its
counsel or would result in disclosure of trade secrets to such representative.
The Observer Rights shall not be assignable in any manner, through operation of
law or otherwise.

          2.11. Directors and Officers Liability Insurance. The Company shall
maintain a standard policy of Directors and Officers liability insurance with a
policy limit of not less than Two Million Dollars ($2,000,000) if in the opinion
of the Board of Directors such policy can be obtained on commercially reasonable
terms.

          2.12. Company Assignment of Rights. The Company agrees to assign to
the Series F Holders, Series E Holders, Series D Holders and the Series C
Holders, on a pro rata basis, any right it may have to purchase the shares of an
employee or consultant of the Company pursuant to a right of first refusal, but
only to the extent that the Company does not fully exercise its right of first
refusal. The rights of the Series F Holders, Series E Holders, Series D Holders
and the Series C Holders to exercise the Company's right of first refusal shall
be governed by the

                                       22
<PAGE>

instruments conferring the grant of the right of first refusal to the Company
(the "Defining Instruments"). The Series F Holders, Series E Holders, Series D
Holders and the Series C Holders shall apportion their rights amongst themselves
pro rata with the right of over-allotment, with such changes to the time periods
as required by the relevant Defining Instrument. The Company's obligation to
assign its right of first refusal shall terminate immediately prior to the
closing of the first firm commitment underwritten public offering of the
Company's securities to the general public or in the event of the distribution
of the proceeds of the sale of substantially all of the Company's assets for
cash or a merger in which the Investors receive securities that are registered
under the 1934 Act.

     3.   Miscellaneous.

          3.1.  Transferability of Shares.,  An Investor may sell, assign,
transfer or pledge all or a portion of the Preferred Stock held by such
Investor, or the common stock issuable upon conversion of the Preferred Stock
(the "Securities"), held by such Investor to (a) any "accredited investor"
within the meaning of Securities and Exchange Commission Rule 501 of Regulation
D, as currently in effect, (b) any pledgee pursuant to a pledge made by an
Investor pursuant to a bona fide loan transaction which creates a mere security
interest, (c) an Investor's ancestors or descendants or spouse or to a trustee
for their benefit, (d) in the case of any Investor that is a company or a
partnership, to its shareholders, partners, or affiliates, (e) any donee
pursuant to a bona fide gift, or (f) any affiliate of the Investor, any
successor company to such Investor or any of such successor company's
affiliates; provided that (i) the Investor making such sale, assignment, pledge,
transfer or gift shall inform the Company thereof prior to effecting it, (ii)
each pledgee, transferee or donee shall first have executed and delivered to the
Company a written agreement to be bound by and comply with all provisions of
this Agreement and any other agreements applicable to the Investor or the
Securities and (iii) if reasonably requested by the Company, such Investor, at
its own expense, shall have furnished the Company with an opinion of counsel,
reasonably satisfactory to the Company that the proposed transfer will not
require registration of the Securities under the Act. It is agreed that the
Company will not require opinions of counsel for transactions made pursuant to
Rule 144 or Rule 144A except in unusual circumstances. The restrictions imposed
by this Section 3.1 shall terminate immediately prior to the closing of the
first firm commitment underwritten public offering of the Company's securities
to the general public or in the event of the distribution of the proceeds of the
sale of substantially all of the Company's assets for cash or a merger in which
the Investors receive securities that are registered under the 1934 Act. Any
securities received pursuant to any stock dividend, stock split,
recapitalization, or exercise of a conversion right shall be subject to this
Section 3.1 to the same extent as the shares of the Company to which they were
issued.

          3.2.  Additional Series F Investors.  Upon the sale of Additional
Series F Shares to Additional Series F Investors, the Company, without prior
action on the part of any of the Investors, shall require each Additional Series
F Investor to execute this Agreement. Each such Additional Series F Investor,
upon execution and delivery of this Agreement by the Company and such Additional
Series F Investor, shall be deemed an Investor hereunder.

          3.3.  Successors and Assigns. Except as otherwise provided herein, the
terms and conditions of this Agreement shall inure to the benefit of and be
binding upon the respective

                                       23
<PAGE>

successors and assigns of the parties (including transferees of any shares of
Registrable Securities). Nothing in this Agreement, express or implied, is
intended to confer upon any party other than the parties hereto or their
respective successors and assigns any rights, remedies, obligations, or
liabilities under or by reason of this Agreement, except as expressly provided
in this Agreement. The parties acknowledge that CDC Financial Services
(Mauritius) Limited is a subsidiary of CDC Group plc. The parties further
acknowledge that it is intended that a majority interest in CDC Group plc will
in due course be sold to private investors, resulting in a change of control of
CDC Group plc. Notwithstanding any provision to the contrary contained herein,
the parties agree that such change of control will not affect any of the
obligations, nor give rise to any rights, of any party under this Agreement, but
for the avoidance of doubt the parties hereby waive any such rights which might
arise under the terms of this Agreement solely as a result of such change of
control.

          3.4.  Governing Law.  This Agreement shall be governed by and
construed under the laws of the State of California as applied to agreements
among California residents entered into and to be performed entirely within
California.

          3.5.  Counterparts.  This Agreement may be executed in two or more
counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument.

          3.6.  Titles and Subtitles. The titles and subtitles used in this
Agreement are used for convenience only and are not to be considered in
construing or interpreting this Agreement.

          3.7.  Notices. Unless otherwise provided, any notice required or
permitted to be given to a party pursuant to the provisions of this Agreement
shall be in writing and shall be effective upon personal delivery or three (3)
days after deposit in the U.S. mail for delivery within the United States, ten
(10) days after deposit in the U.S. mail for delivery outside of the United
States, or one (1) day after deposit with an overnight courier, postage prepaid
and properly addressed to the party to be notified as set forth below such
party's signature or at such other address as such party may designate by ten
(10) days' advance written notice to the other parties hereto.

          3.8.  Expenses. If any action at law or in equity is necessary to
enforce or interpret the terms of this Agreement, the prevailing party shall be
entitled to reasonable attorneys' fees, costs and necessary disbursements in
addition to any other relief to which such party may be entitled.

          3.9.  Amendments and Waivers. Any term of this Agreement may be
amended and the observance of any term of this Agreement may be waived (either
generally or in a particular instance and either retroactively or
prospectively), only with the written consent of the Company and the holders of
a majority of the Registrable Securities then outstanding. Any amendment or
waiver effected in accordance with this paragraph shall be binding upon each
holder of any Registrable Securities then outstanding, each future holder of all
such Registrable Securities, the Company, and any other signatories hereto, and
upon the respective successors

                                       24
<PAGE>

and assigns of such signatories; provided that, without the consent of the
Company and all holders of Registrable Securities then outstanding, no amendment
to this Agreement may be made that (i) modifies this Section 3.9 or (ii) would
effect the holders of the Registrable Securities in a disproportionate manner
(other than any disproportionate results that are due to a difference in the
relative stock ownership in the Company).

          3.10. Severability.  If one or more provisions of this Agreement are
held to be unenforceable under applicable law, such provision shall be excluded
from this Agreement and the balance of the Agreement shall be interpreted as if
such provision were so excluded and shall be enforceable in accordance with its
terms.

          3.11. Aggregation of Stock.  All shares of Registrable Securities held
or acquired by affiliated entities or persons shall be aggregated together for
the purpose of determining the availability of any rights under this Agreement.

          3.12. Entire Agreement; Amendment of Prior Investors' Agreement;
Waiver of Certain Rights Under Prior Investors' Agreements. Effective upon the
later of (i) the Initial Closing (as defined in the Series F Agreement) and (ii)
the execution and delivery of this Agreement by the Company and the Holders of a
majority of the outstanding Registrable Securities (as defined in the Prior
Investors' Agreement), the Prior Investors' Agreement shall be amended and
restated in its entirety as set forth herein and shall be binding upon each
holder of any Registrable Securities then outstanding, each future holder of all
such Registrable Securities, the Company and other signatories hereto, and upon
the respective successors and assigns of such signatories. The Investors (as
defined in the Prior Investors' Rights Agreement) hereby waive, pursuant to
Section 3.9 of the Prior Investors' Agreement, the right, pursuant to Section
2.5 of the Prior Investors' Agreement, to receive notice of and participate in
the sale of shares of Series F Preferred Stock of the Company pursuant to the
Series F Agreements.

                                       25
<PAGE>

          IN WITNESS WHEREOF, the parties have executed this Fourth Amended and
Restated Investors' Rights Agreement as of the date first above written.

  AgraQuest, Inc.

  By: /s/ Pamela G. Marrone
     ------------------------------
       Pamela G. Marrone, President

  1530 Drew Avenue
  Davis, CA 95616

  FOUNDERS:

  Pamela G. Marrone

  /s/ Pamela G. Marrone
  ---------------------------------
  1530 Drew Avenue
  Davis, CA 95616

  Duane Ewing

  /s/ Duane Ewing
  ---------------------------------
  1530 Drew Avenue
  Davis, CA 95616

  Bruce Holm

  /s/ Bruce Holm
  ---------------------------------
  2418 Northwest La Camas Drive
  Camas, WA 98607
<PAGE>

          IN WITNESS WHEREOF, the parties have executed this Fourth Amended and
Restated Investors' Rights Agreement as of the date first above written.

INVESTOR:

By:       ______________________

Name:     ______________________

Address:  ______________________

          ______________________

If an Existing Investor, please complete:

Series B Preferred Stock        _________________________
                                Number of Shares Held

Series C Preferred Stock        _________________________
                                Number of Shares Held

Series D Preferred Stock        _________________________
                                Number of Shares Held

Series E Preferred Stock        _________________________
                                Number of Shares Held

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00027-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00027-of-00352.parquet"}]]